FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Silva-Moraes, MH
   Bispo-Torres, AC
   Barouh, JL
   Lucena, PH
   Armani-Franceschi, G
   Dorea-Bandeira, I
   Vieira, F
   Miranda-Scippa, A
   Quarantini, LC
   Lucena, R
   Bandeira, ID
AF Silva-Moraes, Marcel Henrique
   Bispo-Torres, Ana Cecilia
   Barouh, Judah L.
   Lucena, Pedro H.
   Armani-Franceschi, Giulia
   Dorea-Bandeira, Ingrid
   Vieira, Flayia
   Miranda-Scippa, Angela
   Quarantini, Lucas C.
   Lucena, Rita
   Bandeira, Igor D.
TI Suicidal behavior in individuals with amyotrophic lateral sclerosis: A
   systematic review
SO JOURNAL OF AFFECTIVE DISORDERS
LA English
DT Review
DE Suicide; Suicidal behavior; Suicidal ideation; Amyotrophic lateral
   sclerosis; Motor neuron disease; Wish to die; Depression; Major
   Depressive Disorder
ID QUALITY-OF-LIFE; MENTAL-HEALTH; WISH; DIE; DEPRESSION; DEATH; ALS
AB Background: Amyotrophic Lateral Sclerosis (ALS) leads to a drastic reduction in quality of life, generating intense psychological distress and predisposing those affected to mental illness and, in more severe cases, suicidal behavior.
   Objective: This is a systematic review aiming to estimate the frequency of wish to die, suicide ideation and suicide in individuals with ALS using the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P).
   Methods: The following databases were used: Pubmed/MEDLINE, PsycINFO, Embase, SciELO, Biblioteca Virtual de Saude (BVS), and Cochrane Library. The choice of appropriate descriptors, or their equivalents, to define the search terms was based on the technical and scientific vocabulary of each database.
   Results: 13 articles were included in the present systematic review, of which three were cross-sectional studies, nine were cohort-type and there was one case-control study. The studies show that individuals with ALS have a higher risk of suicide in relation to the general population, and there is evidence that this risk is even higher in the early stages of the disease. Major Depressive Disorder was the most prevalent mental disorder in the studies included. This mental health concern is often undertreated, leading to the increased susceptibility of this population to suicide.
   Limitations: In general, the study samples represent a highly heterogeneous population while many instruments used in the data collection were not uniform.
   Conclusions: The high degree of psychological vulnerability of this population, associated with a greater predisposition to suicidal behavior, should be minimized through public health measures.
C1 [Silva-Moraes, Marcel Henrique; Bispo-Torres, Ana Cecilia; Barouh, Judah L.; Armani-Franceschi, Giulia] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Barouh, Judah L.] Harvard Univ, Neuromodulat Ctr, Spaulding Rehabil Hosp, Harvard Med Sch, Boston, MA 02115 USA.
   [Lucena, Pedro H.] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Dorea-Bandeira, Ingrid] Fac Tecnol & Ciencias, Salvador, BA, Brazil.
   [Miranda-Scippa, Angela; Quarantini, Lucas C.; Lucena, Rita] Univ Fed Bahia, Dept Neurociencias & Saude Mental, Fac Med Bahia, Salvador, BA, Brazil.
   [Dorea-Bandeira, Ingrid; Vieira, Flayia; Quarantini, Lucas C.; Bandeira, Igor D.] Univ Fed Bahia, Lab Neuropsicofarmacol, Serv Psiquiatria, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.
   [Vieira, Flayia; Bandeira, Igor D.] Univ Fed Bahia, Programa Posgrad Med & Saude, Fac Med Bahia, Praca XV Novembro,S-N Largo do Terreiro de Jesus, Salvador, BA, Brazil.
RP Bandeira, ID (corresponding author), Univ Fed Bahia, Lab Neuropsicofarmacol, Serv Psiquiatria, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.; Bandeira, ID (corresponding author), Univ Fed Bahia, Programa Posgrad Med & Saude, Fac Med Bahia, Praca XV Novembro,S-N Largo do Terreiro de Jesus, Salvador, BA, Brazil.
EM igorbandeira@gmail.com
RI Barouh, Judah Leao/AAK-7070-2020; Lucena, Rita/L-9842-2013; Bandeira,
   Igor Dorea/J-8835-2015
OI Barouh, Judah Leao/0000-0002-5309-1175; Lucena,
   Rita/0000-0002-6190-9168; Bandeira, Igor Dorea/0000-0002-6714-2658;
   Vieira, Flavia/0000-0001-5987-2450
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Albert SM, 2005, NEUROLOGY, V65, P68, DOI 10.1212/01.wnl.0000168161.54833.bb
   Averill AJ, 2007, AMYOTROPH LATERAL SC, V8, P243, DOI 10.1080/17482960701374643
   Bandeira Igor D, 2020, CNS Spectr, P1, DOI 10.1017/S1092852919001810
   Bandeira ID, 2018, INT J MED EDUC, V9, P170, DOI 10.5116/ijme.5b1b.b0a2
   Bandeira ID, 2016, J CHILD NEUROL, V31, P918, DOI 10.1177/0883073816630083
   Barreto TM, 2020, DEV MED CHILD NEUROL, V62, P163, DOI 10.1111/dmcn.14321
   Barretto TL, 2019, CLIN NEUROL NEUROSUR, V182, P123, DOI 10.1016/j.clineuro.2019.05.009
   Bremer BA, 2004, ANN BEHAV MED, V28, P119, DOI 10.1207/s15324796abm2802_7
   Chaddha A, 2016, AM J MED, V129, P1145, DOI 10.1016/j.amjmed.2016.05.018
   Correia-Melo FS, 2020, J AFFECT DISORDERS, V264, P527, DOI 10.1016/j.jad.2019.11.086
   Correia-Melo FS, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012414
   Coughlin S.S., 2013, J DEPRESS ANXIETY, V9, P12443, DOI DOI 10.4172/2167-1044.S9-001
   Crawford MJ, 2002, INT REV PSYCHIATR, V14, P6, DOI 10.1080/09540260120114005
   Delfino R.S., 2020, CURR BEHAV NEUROSCI, DOI [10.1007/s40473-020-00201-w, DOI 10.1007/S40473-020-00201-W]
   Eliasen A, 2018, J NEUROL, V265, P1303, DOI 10.1007/s00415-018-8837-4
   Fang F, 2008, BRAIN, V131, P2729, DOI 10.1093/brain/awn161
   Ganzini L, 1999, NEUROLOGY, V52, P1434, DOI 10.1212/WNL.52.7.1434
   Gil J, 2008, EUR J NEUROL, V15, P1245, DOI 10.1111/j.1468-1331.2008.02307.x
   Gourie-Devi M, 2017, NEUROL INDIA, V65, P46, DOI 10.4103/0028-3886.198177
   Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004
   Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421
   Leal GC, 2020, EUR ARCH PSY CLIN N, DOI 10.1007/s00406-020-01110-5
   Lewis DS, 2014, J NEUROSCI NURS, V46, P241, DOI 10.1097/JNN.0000000000000062
   Linden E, 2013, ARQ NEURO-PSIQUIAT, V71, P959, DOI 10.1590/0004-282X20130177
   Maessen M, 2009, NEUROLOGY, V73, P954, DOI 10.1212/WNL.0b013e3181b87983
   Manzur AY, 2009, J NEUROL NEUROSUR PS, V80, P706, DOI 10.1136/jnnp.2008.158329
   Meier SL, 2010, BRAIN, V133, P3444, DOI 10.1093/brain/awq254
   Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI [10.1186/2046-4053-4-1, 10.14306/renhyd.20.2.223]
   Palmieri A, 2010, NEUROL SCI, V31, P735, DOI 10.1007/s10072-010-0332-3
   Rabkin J, 2016, NEUROLOGY, V87, P1320, DOI 10.1212/WNL.0000000000003035
   Rabkin JG, 2015, AMYOTROPH LAT SCL FR, V16, P265, DOI 10.3109/21678421.2014.980428
   Rios Debora Medeiros, 2018, Child Neurol Open, V5, p2329048X18798255, DOI 10.1177/2329048X18798255
   Stephens HE, 2016, AMYOTROPH LAT SCL FR, V17, P206, DOI 10.3109/21678421.2015.1131832
   Studart P, 2016, PSYCHIAT RES, V246, P796, DOI 10.1016/j.psychres.2016.10.045
   Stutzki R, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00443
   Tsai CP, 2013, J EPIDEMIOL, V23, P424, DOI 10.2188/jea.JE20130045
   Verschueren A, 2019, AMYOTROPH LAT SCL FR, V20, P68, DOI 10.1080/21678421.2018.1530265
   von Elm E, 2007, BMJ-BRIT MED J, V335, P806
   Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3
   Zhang YC, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.101619
NR 40
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-0327
EI 1573-2517
J9 J AFFECT DISORDERS
JI J. Affect. Disord.
PD DEC 1
PY 2020
VL 277
BP 688
EP 696
DI 10.1016/j.jad.2020.08.066
PG 9
WC Clinical Neurology; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA OA0DM
UT WOS:000577467600017
PM 32911219
DA 2020-12-15
ER

PT J
AU Carvalho, A
   Sales, HF
   Ventura, P
   Gnoatto-Medeiros, M
   Brites, C
   Lucena, R
AF Carvalho, Alessandra
   Sales, Henrique F.
   Ventura, Paloma
   Gnoatto-Medeiros, Marina
   Brites, Carlos
   Lucena, Rita
TI The neurodevelopmental spectrum of congenital Zika infection: a scoping
   review
SO DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
LA English
DT Review
ID VIRUS-INFECTION; CHILDREN; BORN
AB Aim To describe the standardized neurodevelopmental outcomes after the first year of life in children with congenital Zika syndrome (CZS) and those exposed to Zika virus (ZIKV) during fetal life, but without microcephaly at birth. Method This scoping review included observational studies about the standardized neurodevelopmental outcome in children with CZS or exposed to ZIKV, but without microcephaly, assessed after 12 months of age. The databases searched were MEDLINE/Pubmed, LILACS, Scielo, Scopus, PsycINFO, CINAHL, and Embase. Risk of bias was assessed with the Joanna Briggs Institute Critical Appraisal Checklists. Results Seventeen papers were included: 12 focused on children with CZS, four on children born without microcephaly, and one described both. Only one of the studies about CZS reported a child with microcephaly and typical development; the remainder described a severe pattern of global developmental delay and cerebral palsy. The prevalence of epilepsy was 74.6%. In the reports about children born without microcephaly, 6.9% to 8.7% had some domain with a score below -2 SD, and three children developed autism spectrum disorder. Interpretation CZS is associated with severe global developmental delay and cerebral palsy after 1 year of age. In children born without microcephaly, although most have typical development, some may be at risk for impairments.
C1 [Carvalho, Alessandra; Ventura, Paloma] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Carvalho, Alessandra; Brites, Carlos; Lucena, Rita] Univ Fed Bahia, Bahia Med Sch, Post Grad Program Med & Hlth, Salvador, BA, Brazil.
   [Sales, Henrique F.] Univ Fed Bahia, Bahia Med Sch, Salvador, BA, Brazil.
   [Gnoatto-Medeiros, Marina] Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil.
RP Carvalho, A (corresponding author), SARAH Salvador Hosp, 2782 Tancredo Neves Ave, BR-41820900 Salvador, BA, Brazil.
EM 13110@sarah.br
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Ventura, Paloma A./0000-0002-7487-2958
FU Coordination for the Improvement of Higher Education Personnel (CAPES),
   BrazilCAPES
FX We thank Marilene da ConceicAo Felix da Silva for her contributions to
   the literature search. We also thank the Coordination for the
   Improvement of Higher Education Personnel (CAPES), Brazil, for
   supporting the Post Graduation Program in Medicine and Health, Bahia
   Medical School, Federal University of Bahia, Salvador, Bahia, Brazil.
   This institution had no role in the study design, data collection and
   analysis, decision to publish, or preparation of this manuscript. This
   research did not receive any specific grant from funding agencies in the
   public, commercial, or not-for-profit sectors. The authors have stated
   that they had no interests that might be perceived as posing conflict or
   bias.
CR Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Carvalho A, 2019, BRAIN DEV-JPN, V41, P587, DOI 10.1016/j.braindev.2019.03.005
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   de Carvalho AL, 2018, EMERG INFECT DIS, V24, P2128, DOI 10.3201/eid2411.180883
   Vianna RAD, 2019, J TROP PEDIATRICS, V65, P592, DOI 10.1093/tropej/fmz019
   Faical Adriana Virginia, 2019, BMJ Paediatr Open, V3, pe000486, DOI 10.1136/bmjpo-2019-000486
   FRANCA TLB, 2018, INT J ENV RES PUB HE, V15, pE1990
   Lima Danielly Laís Pereira, 2019, Fisioter. Pesqui., V26, P145, DOI 10.1590/1809-2950/18001626022019
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Melo A, 2020, DEV MED CHILD NEUROL, V62, P221, DOI 10.1111/dmcn.14227
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Soares-Marangoni DD, 2019, DEV NEUROREHABIL, V22, P71, DOI 10.1080/17518423.2018.1437843
   Subissi L, 2018, EMERG INFECT DIS, V24, P1850, DOI 10.3201/eid2410.172079
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura PA, 2020, J DEV BEHAV PEDIATR, V41, P134, DOI 10.1097/DBP.0000000000000722
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
NR 20
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0012-1622
EI 1469-8749
J9 DEV MED CHILD NEUROL
JI Dev. Med. Child Neurol.
PD DEC
PY 2020
VL 62
IS 12
BP 1356
EP 1362
DI 10.1111/dmcn.14675
EA SEP 2020
PG 7
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA OK6PQ
UT WOS:000569156800001
PM 32931050
DA 2020-12-15
ER

PT J
AU Sales, HF
   Cerqueira, C
   Vaz, D
   Medeiros-Rios, D
   Armani-Franceschi, G
   Lucena, PH
   Sternberg, C
   Nobrega, AC
   Luz, C
   Fonseca, D
   Carvalho, AL
   Monteiro, L
   Siqueira, IC
   Bandeira, ID
   Lucena, R
AF Sales, Henrique F.
   Cerqueira, Caroline
   Vaz, Daniel
   Medeiros-Rios, Debora
   Armani-Franceschi, Giulia
   Lucena, Pedro H.
   Sternberg, Carla
   Nobrega, Ana C.
   Luz, Cleber
   Fonseca, Danilo
   Carvalho, Alessandra L.
   Monteiro, Larissa
   Siqueira, Isadora C.
   Bandeira, Igor D.
   Lucena, Rita
TI The impact of botulinum toxin type A in the treatment of drooling in
   children with cerebral palsy secondary to Congenital Zika Syndrome: an
   observational study
SO NEUROLOGICAL RESEARCH
LA English
DT Article; Early Access
DE Cerebral palsy; Congenital Zika Syndrome; drooling; botulinum toxin type
   A; Doppler ultrasonography
ID SIALORRHEA; INJECTIONS; BRAZIL
AB Objective The main aim of this study was to determine the impact of botulinum toxin A (BTX-A) on severity and frequency of drooling in children with Cerebral Palsy (CP) secondary to Congenital Zika Syndrome (CZS). Methods This is a prospective longitudinal observational study including 23 children who received bilateral injections of BTX in the parotid and submandibular glands. The Thomas-Stonell & Greenberg Drooling Severity and Frequency Scale was applied by a multidisciplinary team including Speech, Language and Hearing professionals. The Global Impression of Improvement (GII) Scale was also applied to assess parents' subjective perceptions of therapeutic response. Swallowing was assessed using Doppler ultrasonography. Univariate logistic regression was used to analyse differences between responders and non-responders. Results Participant age varied from 27 to 38 months (mean 31.78, SD = 2.61) all presented with Gross Motor Function Classification System (GMFCS) V. Drooling Severity and Frequency Scale scores ranged from 7 to 9 points (median = 9) prior to BTX administration and from 4 to 6 (median = 6) after. Pre- and post-treatment reduction in drooling severity occurred (Z = -3.746; p < 0.001). No cases of drooling worsening were reported. Only two subjects presented adverse effects attributed to BTX administration. Correlation was only confirmed with GII. Discussion This article presents the safe and positive impact of BTX-A administration guided by anatomical references described in the literature, even on children with microcephaly. Further studies are needed to facilitate the use of Doppler ultrasonography as a tool to characterize changes in sensory processing and motor response following intraoral input in children with CP.
C1 [Sales, Henrique F.; Armani-Franceschi, Giulia] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
   [Cerqueira, Caroline; Vaz, Daniel] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.
   [Medeiros-Rios, Debora; Carvalho, Alessandra L.; Bandeira, Igor D.] Univ Fed Bahia, Fac Med Bahia, Programa Posgrad Med & Saude, Salvador, BA, Brazil.
   [Lucena, Pedro H.] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Sternberg, Carla; Nobrega, Ana C.; Luz, Cleber; Fonseca, Danilo] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Monteiro, Larissa] Univ Fed Bahia, Fac Med Bahia, Dept Pediat, Salvador, BA, Brazil.
   [Siqueira, Isadora C.] Fundacao Oswaldo Cruz, Inst Goncalo Muniz, Salvador, BA, Brazil.
   [Bandeira, Igor D.] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Serv Psiquiatria, Lab Neuropsicofarmacol, Salvador, BA, Brazil.
   [Lucena, Rita] Univ Fed Bahia, Fac Med Bahia, Dept Neurociencias & Saude Mental, Salvador, BA, Brazil.
RP Lucena, R (corresponding author), Univ Fed Bahia, BR-40110100 Salvador, BA, Brazil.
EM rcslucena@yahoo.com.br
RI de Siqueira, Isadora Cristina/R-9953-2016; Nobrega, Ana
   Caline/ABC-5608-2020; Lucena, Rita/L-9842-2013; Bandeira, Igor
   Dorea/J-8835-2015
OI de Siqueira, Isadora Cristina/0000-0002-2520-4099; Nobrega, Ana
   Caline/0000-0002-6509-8702; Lucena, Rita/0000-0002-6190-9168; Bandeira,
   Igor Dorea/0000-0002-6714-2658; Reis, AlessanRSS/0000-0001-8486-7469
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Alrefai AH, 2009, CLIN NEUROL NEUROSUR, V111, P79, DOI 10.1016/j.clineuro.2008.09.001
   Bandeira ID, 2018, INT J MED EDUC, V9, P170, DOI 10.5116/ijme.5b1b.b0a2
   Bandeira ID, 2017, MUSCLE NERVE, V56, pE10, DOI 10.1002/mus.25610
   Barreto TM, 2020, DEV MED CHILD NEUROL, V62, P163, DOI 10.1111/dmcn.14321
   Bothwell JE, 2002, PEDIATR NEUROL, V27, P18, DOI 10.1016/S0887-8994(02)00381-8
   Cagliari Cibele Fontoura, 2009, Braz. j. otorhinolaryngol., V75, P706, DOI 10.1590/S1808-86942009000500016
   Lagos HNC, 2013, INT ARCH OTORHINOLAR, V17, P383, DOI 10.1055/s-0033-1353369
   Dohar JE, 2019, INT J PEDIATR OTORHI, V116, P97, DOI 10.1016/j.ijporl.2018.10.035
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gonzalez-Luis MD, 2017, AM J PHYS MED REHAB, V96, P68, DOI 10.1097/PHM.0000000000000525
   Gubbay A, 2019, INT J PEDIATR OTORHI, V124, P124, DOI 10.1016/j.ijporl.2019.05.044
   Jackson CE, 2009, MUSCLE NERVE, V39, P137, DOI 10.1002/mus.21213
   Lim ECH, 2010, NAT REV NEUROL, V6, P624, DOI 10.1038/nrneurol.2010.149
   Ondo WG, 2004, NEUROLOGY, V62, P37, DOI 10.1212/01.WNL.0000101713.81253.4C
   Porte M, 2014, EUR J PAEDIATR NEURO, V18, P649, DOI 10.1016/j.ejpn.2014.05.007
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Rodwell K, 2012, DEV MED CHILD NEUROL, V54, P977, DOI 10.1111/j.1469-8749.2012.04370.x
   Scofano Dias BL, 2016, J PEDIAT RIO J, DOI [10.1016/j.jpedp.2016.06.002, DOI 10.1016/J.JPEDP.2016.06.002]
   Senner JE, 2004, DEV MED CHILD NEUROL, V46, P801, DOI 10.1017/S0012162204001409
   Thomas-Stonell N, 1988, Dysphagia, V3, P73, DOI 10.1007/BF02412423
   van Hulst K, 2017, DEV MED CHILD NEUROL, V59, P531, DOI 10.1111/dmcn.13333
NR 21
TC 0
Z9 0
U1 4
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0161-6412
EI 1743-1328
J9 NEUROL RES
JI Neurol. Res.
DI 10.1080/01616412.2020.1820698
EA SEP 2020
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA NN7AE
UT WOS:000568935800001
PM 32915712
DA 2020-12-15
ER

PT J
AU Faical, AVB
   de Oliveira, JMGC
   Andrade, NC
   Lucena, R
   Acosta, AX
   de Siqueira, IC
AF Barros Faical, Adriana Virginia
   Gomes Cabral de Oliveira, Juliana Menezes
   Andrade, Nara C.
   Lucena, Rita
   Acosta, Angelina Xavier
   de Siqueira, Isadora Cristina
TI Socioemotional Status of Children With Uterine Exposure to the Zika
   Virus
SO PEDIATRIC NEUROLOGY
LA English
DT Letter
DE Congenital Zika Infection; Neurodevelopment; Socioemotional status; Zika
   virus
C1 [Barros Faical, Adriana Virginia] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.
   [Gomes Cabral de Oliveira, Juliana Menezes; de Siqueira, Isadora Cristina] Fundacao Oswaldo Cruz Fiocruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [Andrade, Nara C.] Univ Catolica Salvador, Dept Psicol, Salvador, BA, Brazil.
   [Lucena, Rita; Acosta, Angelina Xavier] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@fiocruz.br
RI Lucena, Rita/L-9842-2013; de Siqueira, Isadora Cristina/R-9953-2016
OI Lucena, Rita/0000-0002-6190-9168; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [443875/2018-9, PPSUS/BA-FAPESB003/2017/SESAB/CNPq/MS
   (5125/2017)]
FX National Council for Scientific and Technological Development (CNPq)
   (443875/2018-9) and PPSUS/BA-FAPESB003/2017/SESAB/CNPq/MS (5125/2017).
CR Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Oliveira JV, 2018, ABSTRACT INT J INFEC, V73, P3
   Trentacosta CJ, 2007, EMOTION, V7, P77, DOI 10.1037/1528-3542.7.1.77
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   Weiss LG, BAYLEY ILL CLIN USE
NR 6
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD FEB
PY 2020
VL 103
BP 86
EP 88
DI 10.1016/j.pediatrneurol.2019.07.020
PG 3
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA KI3GT
UT WOS:000511237900016
PM 31735568
DA 2020-12-15
ER

PT J
AU Lucena, PH
   Armani-Franceschi, G
   Bispo-Torres, AC
   Bandeira, ID
   Lucena, MFG
   Maldonado, I
   Veiga, MF
   Miguel, D
   Lucena, R
AF Lucena, Pedro H.
   Armani-Franceschi, Giulia
   Bispo-Torres, Ana Cecilia
   Bandeira, Igor D.
   Lucena, Mariana F. G.
   Maldonado, Igor
   Veiga, Marielza F.
   Miguel, Diego
   Lucena, Rita
TI KPTN gene homozygous variant-related syndrome in the northeast of
   Brazil: A case report
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Article
DE homozygous variant; intellectual disability; KPTN; macrocephaly
ID MUTATION; PROTEIN
AB Alteration of the KPTN gene, responsible for the coding of kaptin (a protein involved in actin cytoskeletal dynamics), causes a syndrome characterized by macrocephaly, neurodevelopmental delay and epileptic seizures. We report the first Brazilian case of KPTN gene variation, previously described in nine subjects from four interlinked families from an Amish community in Ohio, two Estonian siblings and a 9-year-old boy from Kansas City. We report a case of KPTN-related syndrome in a 5-year-old child which presented macrocephaly, muscular hypotonia, and global development delay. The neurological examination revealed below-expected performance in coordination and balance tests, dyspraxia, and hand-mouth synkinesia. Expressive language was characterized by phono-articulatory imprecision, abundance of phonological processes and morphosyntactic immaturity. Neuropsychological assessment revealed intellectual disability with impairment of verbal and executive functions. Exome sequencing was performed. Analysis revealed a homozygous 2-nucleotide duplication c.597_598dup p.(Ser200Ilefs*55) in the KPTN gene, which is predicted to lead to a translational frameshift and formation of a premature stop codon. The phenotypic profile is similar to the cases described in the other families. Presence of macrocephaly and delayed development indicate the possibility of KPTN gene variation. Genetic testing should be carried out at an early stage in order to reach a timely diagnosis.
C1 [Lucena, Pedro H.; Lucena, Mariana F. G.] Escola Bahiana Med & Saude Publ, Dept Med, Salvador, BA, Brazil.
   [Armani-Franceschi, Giulia; Bispo-Torres, Ana Cecilia; Bandeira, Igor D.; Lucena, Rita] Univ Fed Bahia, Fac Med Bahia, Dept Neurociencias & Saude Mental, Salvador, BA, Brazil.
   [Bandeira, Igor D.] Univ Fed Bahia, Fac Med Bahia, Programa Posgrad Med & Saude, Salvador, BA, Brazil.
   [Maldonado, Igor] Le Studium Loire Valley Inst Adv Studies, Orleans, France.
   [Maldonado, Igor] Univ Tours, INSERM, iBrain, UMR 1253, Tours, France.
   [Maldonado, Igor] CHRU Tours, Tours, France.
   [Veiga, Marielza F.; Miguel, Diego] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.
RP Lucena, R (corresponding author), Univ Fed Bahia, Fac Med Bahia, Praca 15 Novembro S-N Largo Terreiro Jesus, Salvador, BA, Brazil.
EM rcslucena@yahoo.com.br
RI Maldonado, Igor/B-6806-2015; Bandeira, Igor Dorea/J-8835-2015; Lucena,
   Rita/L-9842-2013
OI Maldonado, Igor/0000-0001-6037-0407; Bandeira, Igor
   Dorea/0000-0002-6714-2658; Lucena, Rita/0000-0002-6190-9168
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES)CAPES [001]
FX Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil
   (CAPES), Grant/Award Number: Finance Code 001
CR Alfei E, 2014, AM J MED GENET A, V164, P3154, DOI 10.1002/ajmg.a.36746
   Baple EL, 2014, AM J HUM GENET, V94, P87, DOI 10.1016/j.ajhg.2013.10.001
   Bearer EL, 2000, ANN HUM GENET, V64, P189, DOI 10.1046/j.1469-1809.2000.6430189.x
   Bearer EL, 1999, EUR J CELL BIOL, V78, P117, DOI 10.1016/S0171-9335(99)80013-2
   Chen TY, 2003, BIOCHEM BIOPH RES CO, V303, P1114, DOI 10.1016/S0006-291X(03)00482-0
   Dent EW, 2011, CURR OPIN NEUROBIOL, V21, P175, DOI 10.1016/j.conb.2010.08.013
   Gonzalez-Mantilla AJ, 2016, JAMA PSYCHIAT, V73, P275, DOI 10.1001/jamapsychiatry.2015.2692
   Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]
   Kessels MM, 2011, EUR J CELL BIOL, V90, P926, DOI 10.1016/j.ejcb.2010.08.011
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Niedermeyer E, 1997, CLIN ELECTROENCEPHAL, V28, P36, DOI 10.1177/155005949702800107
   Pajusalu S, 2015, AM J MED GENET A, V167, P1913, DOI 10.1002/ajmg.a.37105
   Pedicelli S, 2014, J CLIN ENDOCR METAB, V99, P4455, DOI 10.1210/jc.2014-2702
   Samanta D, 2015, ACTA NEUROL BELG, V115, P779, DOI 10.1007/s13760-014-0413-9
   Svitkina T, 2010, J NEUROSCI, V30, P14937, DOI 10.1523/JNEUROSCI.4276-10.2010
   Thiffault I., 2018, J CASE GENETIC HERED, V1, P102
NR 16
TC 2
Z9 2
U1 4
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR
PY 2020
VL 182
IS 4
BP 762
EP 767
DI 10.1002/ajmg.a.61492
EA JAN 2020
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA KS9PG
UT WOS:000510119500001
PM 31999056
DA 2020-12-15
ER

PT J
AU Guimaraes, RSQ
   Bandeira, ID
   Barretto, BL
   Barretto, TL
   Wanke, T
   Alves, COC
   Carvalho, CF
   Lucena, PH
   Rodrigues-Silva, L
   Lucena, R
AF Guimaraes, R. S. Q.
   Bandeira, I. D.
   Barretto, B. L.
   Barretto, T. L.
   Wanke, T.
   Alves, C. O. C.
   Carvalho, C. F.
   Lucena, P. H.
   Rodrigues-Silva, L.
   Lucena, R.
TI Transcranial-direct current stimulation on attention and inhibitory
   control of children and adolescents with ADHD: A randomized, crossover,
   triple-blind, sham-controlled study
SO EUROPEAN NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 32nd Congress of the European-College-of-Neuropsychopharmacology (ECNP)
CY SEP 07-10, 2019
CL Copenhagen, DENMARK
SP European Coll Neuropsychopharmacol
C1 [Guimaraes, R. S. Q.; Bandeira, I. D.; Barretto, T. L.; Lucena, R.] Univ Fed Bahia, Dept Neurosci & Mental Hlth, Salvador, BA, Brazil.
   [Barretto, B. L.] Univ Fed Bahia, Med Sch Bahia, Salvador, BA, Brazil.
   [Wanke, T.; Alves, C. O. C.; Carvalho, C. F.] Univ Fed Bahia, Inst Psychol, Salvador, BA, Brazil.
   [Lucena, P. H.] Harvard Univ, Neuromodulat Ctr, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA.
   [Rodrigues-Silva, L.] Univ Fed Bahia, Dept Pediat, Salvador, BA, Brazil.
RI Bandeira, Igor Dorea/J-8835-2015
OI Bandeira, Igor Dorea/0000-0002-6714-2658
CR Bandeira ID, 2016, J CHILD NEUROL, V31, P918, DOI 10.1177/0883073816630083
NR 1
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0924-977X
EI 1873-7862
J9 EUR NEUROPSYCHOPHARM
JI Eur. Neuropsychopharmacol.
PD DEC
PY 2019
VL 29
SU 6
MA P.829
BP S551
EP S552
DI 10.1016/j.euroneuro.2019.09.693
PG 2
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA JV9CR
UT WOS:000502657505010
DA 2020-12-15
ER

PT J
AU Vila-Nova, C
   Lucena, PH
   Lucena, R
   Armani-Franceschi, G
   Campbell, FQ
AF Vila-Nova, Camila
   Lucena, Pedro H.
   Lucena, Rita
   Armani-Franceschi, Giulia
   Campbell, Fernanda Q.
TI Effect of Anodal tDCS on Articulatory Accuracy, Word Production, and
   Syllable Repetition in Subjects with Aphasia: A Crossover,
   Double-Blinded, Sham-Controlled Trial
SO NEUROLOGY AND THERAPY
LA English
DT Article
DE Aphasia; Broca's area; Language rehabilitation; Speech accuracy; Stroke;
   Transcranial direct-current stimulation (tDCS)
ID DIRECT-CURRENT STIMULATION; INFERIOR FRONTAL GYRUS; EARLY
   REHABILITATION; POSTSTROKE APHASIA; ISCHEMIC-STROKE; BROCAS AREA;
   LANGUAGE; SPEECH; MODULATION; AGREEMENT
AB Introduction Transcranial direct-current stimulation (tDCS) has been used to modulate and induce changes in brain function and excitability. tDCS is a promising tool for the treatment of aphasia. Objective To evaluate whether tDCS improves articulatory accuracy and speech production in patients with aphasia after stroke. Methods and Results Twelve right-handed subjects participated in a double-blind, sham-controlled, crossover offline trial. We assessed (1) articulatory accuracy at a naming task, (2) number of words correctly produced, (3) number of syllables repeated correctly, and (4) qualitative assessment of speech. Articulatory accuracy improved when using tDCS over Broca's area in subjects with aphasia post-stroke (p <= 0.05). Qualitative improvement in the naming and syllable repetition tasks was observed, but the difference was not statistically significant (respectively, p = 0.15 and p = 0.79). Conclusion The current results corroborate the potential of tDCS to be used as an alternative and complementary treatment for individuals with aphasia.
C1 [Vila-Nova, Camila] Kroton, Uniao Metropolitana Educ & Cultura UNIME, Ave Luis Tarquinio Pontes, BR-600 Lauro De Freitas, BA, Brazil.
   [Vila-Nova, Camila] Univ Estado Bahia, Ave Luis Tarquinio Pontes, BR-600 Lauro De Freitas, BA, Brazil.
   [Lucena, Pedro H.] Bahiana Sch Med & Publ Hlth, Ave Dom Joao VI 275, Salvador, BA, Brazil.
   [Lucena, Rita] Univ Fed Bahia, Sch Med Bahia, Ave Luis Viana Filho S-N, Salvador, BA, Brazil.
   [Armani-Franceschi, Giulia] Univ Fed Bahia, Ave Luis Viana Filho S-N, Salvador, BA, Brazil.
   [Campbell, Fernanda Q.] Brandeis Univ, Heller Sch Social Policy & Management, 415 South St, Waltham, MA USA.
RP Vila-Nova, C (corresponding author), Kroton, Uniao Metropolitana Educ & Cultura UNIME, Ave Luis Tarquinio Pontes, BR-600 Lauro De Freitas, BA, Brazil.; Vila-Nova, C (corresponding author), Univ Estado Bahia, Ave Luis Tarquinio Pontes, BR-600 Lauro De Freitas, BA, Brazil.
EM camivnova@gmail.com
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Lucena, Pedro/0000-0003-1148-7806
CR Baker JM, 2010, STROKE, V41, P1229, DOI 10.1161/STROKEAHA.109.576785
   Boggio PS, 2010, EUR J NEUROSCI, V31, P593, DOI 10.1111/j.1460-9568.2010.07080.x
   Bose A, 2008, BRAIN LANG, V106, P4, DOI 10.1016/j.bandl.2008.03.002
   Cappa SF, 2005, EUR J NEUROL, V12, P665
   Cattaneo Z, 2011, NEUROSCIENCE, V183, P64, DOI 10.1016/j.neuroscience.2011.03.058
   DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744
   de Aguiar V, 2015, CORTEX, V63, P296, DOI 10.1016/j.cortex.2014.08.015
   Dhamoon MS, 2012, STROKE, V43, P2180, DOI 10.1161/STROKEAHA.112.658922
   Elsner B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009760.pub3
   Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c
   Fadiga L, 2009, ANN NY ACAD SCI, V1169, P448, DOI 10.1111/j.1749-6632.2009.04582.x
   Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070
   Fiori V, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00269
   Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098
   Floel A, 2011, STROKE, V42, P2065, DOI 10.1161/STROKEAHA.110.609032
   Fridriksson J, 2019, BRAIN STIMUL, V12, P190, DOI 10.1016/j.brs.2018.09.016
   Fridriksson J, 2018, BRAIN STIMUL, V11, P1276, DOI 10.1016/j.brs.2018.08.009
   Fridriksson J, 2018, JAMA NEUROL, V75, P1470, DOI 10.1001/jamaneurol.2018.2287
   Fridriksson J, 2011, STROKE, V42, P819, DOI 10.1161/STROKEAHA.110.600288
   Glize B, 2017, EUR J PHYS REHAB MED, V53, P249, DOI 10.23736/S1973-9087.16.04255-6
   Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0
   Goldstein LB, 2001, STROKE, V32, P1091, DOI 10.1161/01.STR.32.5.1091
   Goodwin C., 2002, CONVERSATION BRAIN D, P90
   Hesse S, 2007, RESTOR NEUROL NEUROS, V25, P9
   Holland R, 2011, CURR BIOL, V21, P1403, DOI 10.1016/j.cub.2011.07.021
   Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9
   Jakubovicz R, 2005, TESTE REABILITACAO A
   Jung IY, 2011, ANN REHABIL MED-ARM, V35, P460, DOI 10.5535/arm.2011.35.4.460
   Kadosh RC, 2010, CURR BIOL, V20, P2016, DOI 10.1016/j.cub.2010.10.007
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lee SY, 2013, ANN REHABIL MED-ARM, V37, P603, DOI 10.5535/arm.2013.37.5.603
   Lesser R, 2003, LINGUISTICS APHASIA
   LESSER RP, 1984, BRAIN, V107, P275, DOI 10.1093/brain/107.1.275
   Marangolo P, 2011, BEHAV BRAIN RES, V225, P498, DOI 10.1016/j.bbr.2011.08.008
   Marangolo P, 2016, J COGNITIVE NEUROSCI, V28, P724, DOI 10.1162/jocn_a_00927
   Marangolo P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00539
   Marangolo P, 2013, RESTOR NEUROL NEUROS, V31, P63, DOI 10.3233/RNN-120268
   Meister IG, 2003, NEUROPSYCHOLOGIA, V41, P401, DOI 10.1016/S0028-3932(02)00179-3
   Monti A, 2008, J NEUROL NEUROSUR PS, V79, P451, DOI 10.1136/jnnp.2007.135277
   Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916
   Norise C, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00260
   Polanowska KE, 2013, RESTOR NEUROL NEUROS, V31, P761, DOI 10.3233/RNN-130333
   Polanowska KE, 2013, NEUROL NEUROCHIR POL, V47, P414, DOI 10.5114/ninp.2013.38221
   Pompeia S, 2003, ARQ NEURO-PSIQUIAT, V61, P916, DOI 10.1590/S0004-282X2003000600005
   RDC T, 2010, R LANG ENV STAT COMP, V2010
   Sebastian R, 2016, NEUROREHABILITATION, V39, P141, DOI 10.3233/NRE-161346
   Shah-Basak PP, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00201
   SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174
   Thair H, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00641
   Vines BW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00230
   Winhuisen L, 2007, STROKE, V38, P1286, DOI 10.1161/01.STR.0000259632.04324.6c
NR 51
TC 2
Z9 2
U1 1
U2 6
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 2193-8253
EI 2193-6536
J9 NEUROL THER
JI Neurol. Ther.
PD DEC
PY 2019
VL 8
IS 2
BP 411
EP 424
DI 10.1007/s40120-019-00149-4
PG 14
WC Clinical Neurology
SC Neurosciences & Neurology
GA JN1XF
UT WOS:000496695000017
PM 31432434
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU de Carvalho, AL
   Ventura, P
   Taguchi, T
   Brandi, I
   Brites, C
   Lucena, R
AF de Carvalho, Alessandra Lemos
   Ventura, Paloma
   Taguchi, Tania
   Brandi, Ivar
   Brites, Carlos
   Lucena, Rita
TI Cerebral Palsy in Children With Congenital Zika Syndrome: A 2-Year
   Neurodevelopmental Follow-up
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE Zika virus; congenital Zika; cerebral palsy; neurodevelopment
ID INFANT NEUROLOGICAL EXAMINATION; AGE
AB Objective: To describe the 2-year neurodevelopmental outcome in children with cerebral palsy associated with congenital Zika (CZ) and explore variables associated with a more severe presentation. Methods: Data on 69 children with cerebral palsy associated with CZ, followed in a neurorehabilitation hospital, who consecutively attended the neurodevelopmental assessment at 2 years of age, were collected. Bayley III Scales of Infant and Toddler Development, Hammersmith Infant Neurological Examination, and Gross Motor Function Classification System were used for the outcome evaluation. Descriptive and inferential statistical analysis were performed. Results: The median age at follow-up was of 24.0 (23-32) months. Only 3 (4.3%) children were not microcephalic. The majority presented with bilateral (94.2%), spastic (100.0%), Gross Motor Function Classification System grade IV or V (92.8%) cerebral palsy, epilepsy (73.1%), extremely low performances on cognitive (94.2%), language (95.7%), and motor (95.7%) Bayley-III Scales of Infant and Toddler Development Test scores. The median Hammersmith Infant Neurological Examination score was of 21.0 (range 9-75). There was a correlation between birth head circumference with the cognitive (r = 0.3, P < .01), language (r = 0.3, P < .01), and motor (r = 0.3, P < .01) Bayley-III Scales of Infant and Toddler Development Test scores, as well as with the Hammersmith Infant Neurological Examination score (r = 0.2, P < .03). An association was observed between an inferior median Hammersmith Infant Neurological Examination score with congenital microcephaly (P = .04), arthrogryposis (P = .02), and epilepsy in the first year (P < .01). Conclusion: Cerebral palsy related to CZ presents with a severe global impairment at a 2-year follow-up. Birth head circumference, arthrogryposis, and early epilepsy are associated with a worse outcome and may be considered as prognostic markers. These findings are important for the neurorehabilitation planning, parents' guiding, and future prognostic studies.
C1 [de Carvalho, Alessandra Lemos; Ventura, Paloma; Taguchi, Tania; Brandi, Ivar] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Brites, Carlos; Lucena, Rita] Univ Fed Bahia, Salvador, BA, Brazil.
RP de Carvalho, AL (corresponding author), SARAH Salvador Hosp, Ave Tancredo Neves,2782 Caminho Arvores, BR-41820900 Salvador, BA, Brazil.
EM 13110@sarah.br
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168
CR Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Botelho Ana Carla Gomes, 2016, Rev. Bras. Saude Mater. Infant., V16, P39, DOI 10.1590/1806-9304201600s100004
   BRASIL, 2018, B EPIDEMIOLOGICO, V49, P1, DOI DOI 10.1111/are.13485
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Carvalho A, 2019, BRAIN DEV-JPN, V41, P587, DOI 10.1016/j.braindev.2019.03.005
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   de Carvalho AL, 2018, EMERG INFECT DIS, V24, P2128, DOI 10.3201/eid2411.180883
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Melo A, 2020, DEV MED CHILD NEUROL, V62, P221, DOI 10.1111/dmcn.14227
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689
   Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x
   Pan American Health Organization Organization PAHOWH, 2016, NEUR SYNDR CONG AN Z
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Romeo DM, 2016, DEV MED CHILD NEUROL, V58, P240, DOI 10.1111/dmcn.12876
   Romeo DMM, 2008, EUR J PAEDIATR NEURO, V12, P24, DOI 10.1016/j.ejpn.2007.05.006
   Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Soares-Marangoni D, 2018, DEV NEUROREHABIL, V16, P1
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, 2017, ZIK VIR MICR GUILL B
NR 25
TC 4
Z9 4
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD MAR
PY 2020
VL 35
IS 3
BP 202
EP 207
AR 0883073819885724
DI 10.1177/0883073819885724
EA NOV 2019
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA KF9TL
UT WOS:000497623200001
PM 31718421
DA 2020-12-15
ER

PT J
AU Barreto, TM
   Bento, MN
   Barreto, TM
   Jagersbacher, JG
   Jones, NS
   Lucena, R
   Bandeira, ID
AF Barreto, Tainara M.
   Bento, Mayara N.
   Barreto, Tamiris M.
   Jagersbacher, Joao Gabriel
   Jones, Nathalia S.
   Lucena, Rita
   Bandeira, Igor D.
TI Prevalence of depression, anxiety, and substance-related disorders in
   parents of children with cerebral palsy: a systematic review
SO DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
LA English
DT Review
ID QUALITY-OF-LIFE; MENTAL-HEALTH; MOTHERS; STRESS; INTERVENTION; BURDEN;
   FAMILY; CALL
AB Aim To estimate the prevalence of mental illness in parents of children with cerebral palsy (CP). Method This is a systematic review that follows the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols in the search for observational studies determining the prevalence of depression, anxiety, and substance abuse in parents of individuals with CP. The information sources used for this study were: PubMed, SciELO, Cochrane Library, Clinical Trials, and Biblioteca Virtual de Saude. Results Fourteen articles were selected and included, investigating 1264 mothers and 105 fathers of children with CP. Data extracted for analysis were divided into three categories: study data, data about participants with CP, and data about parents. All studies included volunteer parents, of whom 95 per cent were female. Interpretation CP is related to a higher prevalence of symptoms of depression and anxiety in parents. Factors such as a child's degree of functionality and socioeconomic level may influence the frequency of mental disorders in parents. However, these studies have heterogeneous samples and applied different criteria to characterize their populations. What this paper adds
   Depression and anxiety are more prevalent for parents of children with cerebral palsy (CP) than parents of typically developing children. The child's illness severity is a risk factor for mental illness in parents of children with CP. The more time spent on child care, the higher the risk of mental illness among mothers of children with CP. There is a lack of reliable data in the literature on substance abuse in parents of children with CP.
C1 [Barreto, Tainara M.; Bento, Mayara N.; Barreto, Tamiris M.; Jagersbacher, Joao Gabriel; Jones, Nathalia S.; Lucena, Rita; Bandeira, Igor D.] Univ Fed Bahia, Med Sch Bahia, Dept Neurosci & Mental Hlth, Praca 15 Novembro S-N, BR-40025010 Salvador, BA, Brazil.
   [Bandeira, Igor D.] Univ Fed Bahia, Med Sch Bahia, Postgrad Program Med & Hlth, Salvador, BA, Brazil.
RP Bandeira, ID (corresponding author), Univ Fed Bahia, Med Sch Bahia, Dept Neurosci & Mental Hlth, Praca 15 Novembro S-N, BR-40025010 Salvador, BA, Brazil.
EM igordbandeira@gmail.com
RI Bandeira, Igor Dorea/J-8835-2015; Lucena, Rita/L-9842-2013
OI Bandeira, Igor Dorea/0000-0002-6714-2658; Lucena,
   Rita/0000-0002-6190-9168
CR Al-Gamal E, 2013, SCAND J CARING SCI, V27, P624, DOI 10.1111/j.1471-6712.2012.01071.x
   Albert PR, 2015, J PSYCHIATR NEUROSCI, V40, P219, DOI 10.1503/jpn.150205
   Bandeira ID, 2018, INT J MED EDUC, V9, P170, DOI 10.5116/ijme.5b1b.b0a2
   Bandeira ID, 2016, J CHILD NEUROL, V31, P918, DOI 10.1177/0883073816630083
   Barretto TL, 2019, CLIN NEUROL NEUROSUR, V182, P123, DOI 10.1016/j.clineuro.2019.05.009
   Bharadwaj P, 2017, ECON LETT, V159, P57, DOI 10.1016/j.econlet.2017.06.028
   Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x
   Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8
   Dalgalarrondo P, 2008, PSICOPATOLOGIA SEMIO
   DeSocio J, 2015, J CHILD ADOL PS NURS, V28, P70, DOI 10.1111/jcap.12106
   Dirks T, 2011, DEV MED CHILD NEUROL, V53, P62, DOI 10.1111/j.1469-8749.2011.04067.x
   Finch-Edmondson M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00015
   Fleming MK, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0476-6
   Freitas P. M., 2014, ESTUDOS PESQUISAS PS, V14, P453
   Freitas PMd, 2005, ARQ BRAS PSICOL, V57, P46
   Guillamon N, 2013, J CLIN NURS, V22, P1579, DOI 10.1111/jocn.12124
   Ketelaar M, 2008, CHILD CARE HLTH DEV, V34, P825, DOI 10.1111/j.1365-2214.2008.00876.x
   Krstic T, 2015, RES DEV DISABIL, V47, P135, DOI 10.1016/j.ridd.2015.09.009
   Liu JM, 1999, INT J EPIDEMIOL, V28, P949, DOI 10.1093/ije/28.5.949
   Mehmedinovic Senad, 2012, Acta Med Iran, V50, P819
   Moher D, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0087-2
   Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2
   Pereira LM, 2014, INTERACAO PSICOLOGIA, V18, P37
   Rios DM, 2018, CHILD NEUROL OPEN, V5
   Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028
   Rosenbaum P, 2011, DEV MED CHILD NEUROL, V53, P68, DOI 10.1111/j.1469-8749.2011.04068.x
   Sajedi Firoozeh, 2010, Acta Med Iran, V48, P250
   Saleem GT, 2019, ARCH PHYS MED REHAB, V100, P724, DOI 10.1016/j.apmr.2018.10.011
   Sawyer MG, 2011, DEV MED CHILD NEUROL, V53, P338, DOI 10.1111/j.1469-8749.2010.03848.x
   Sun JM, 2017, STEM CELL TRANSL MED, V6, P2071, DOI 10.1002/sctm.17-0102
   Tekinarslan IC, 2013, PSYCHOL REP, V112, P266, DOI 10.2466/21.02.15.PR0.112.1.266-287
   vonsElm E, 2007, BMJ-BRIT MED J, V335, P806
   Wayte S, 2012, ACTA PAEDIATR, V101, P618, DOI 10.1111/j.1651-2227.2012.02603.x
   Whittingham K, 2013, CHILD CARE HLTH DEV, V39, P366, DOI 10.1111/j.1365-2214.2012.01396.x
   Yilmaz H, 2013, EUR J PHYS REHAB MED, V49, P823
NR 35
TC 4
Z9 4
U1 1
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0012-1622
EI 1469-8749
J9 DEV MED CHILD NEUROL
JI Dev. Med. Child Neurol.
PD FEB
PY 2020
VL 62
IS 2
BP 163
EP +
DI 10.1111/dmcn.14321
EA AUG 2019
PG 7
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA KB3TH
UT WOS:000478850100001
PM 31381150
DA 2020-12-15
ER

PT J
AU Carvalho, A
   Brites, C
   Mochida, G
   Ventura, P
   Fernandes, A
   Lage, ML
   Taguchi, T
   Brandi, I
   Silva, A
   Franceschi, G
   Lucena, P
   Lucena, R
AF Carvalho, Alessandra
   Brites, Carlos
   Mochida, Ganeshwaran
   Ventura, Paloma
   Fernandes, Adriana
   Lage, Maria Lucia
   Taguchi, Thnia
   Brandi, Ivar
   Silva, Alfredo
   Franceschi, Giulia
   Lucena, Pedro
   Lucena, Rita
TI Clinical and neurodevelopmental features in children with cerebral palsy
   and probable congenital Zika
SO BRAIN & DEVELOPMENT
LA English
DT Article
DE Zika virus; Cerebral palsy; Neurodevelopment
ID VIRUS-INFECTION; INFANTS; BRAZIL; OUTCOMES; GROWTH; BORN; AGE
AB Objective: To describe the neurological and neurodevelopmental features at 1 year of age in children with cerebral palsy (CP) related to probable congenital Zika (CZ), followed in a referral neurorehabilitation hospital.
   Methods. - Data on 82 children with CP associated with probable CZ, who consecutively attended the neurodevelopmental and neurological assessment around one year of age, were collected. For neurodevelopmental evaluation, Bayley-III Scales of Infant and Toddler Development was used. Descriptive statistical analysis was performed.
   Results: The children were admitted into the rehabilitation program at a young age (mean age: 4.8 months, SD 3.1), followed beyond the first year of life (mean age of follow up: 13.2 months, SD 2.1), born to young mothers (mean age: 28.1 years, SD 5.9), in their first pregnancy (62.2%). The majority had severe congenital microcephaly (62.0%), spastic CP (96.3%), epilepsy (63.4%), absent expected postural reactions (93.2%), abnormal persistence of primitive reflexes (94.7%), and severe neuroimaging abnormalities, predominantly calcifications (97.6%). Extremely low performances on cognitive (95.1%), language (97.6%) and motor (97.6%) developmental composite scores were observed. There was a correlation between the cognitive score with the birth head circumference (HC) (r = 0.3, p = 0.01) and with the follow up HC (r = 0.4, p < 0.01), as well as between the follow up HC with the motor score (r = 0.2, p = 0.03).
   Conclusion: Congenital Zika may be associated with a severe form of CP, mainly bilateral spastic, with a severe global neurodevelopmental impairment and early signs of a poor prognosis for independent walking. Head circumference may be a prognostic marker among those children. These results may help establish goals for the rehabilitation program and identify priority health services. (C) 2019 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.
C1 [Carvalho, Alessandra; Ventura, Paloma; Fernandes, Adriana; Taguchi, Thnia; Brandi, Ivar; Silva, Alfredo] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Brites, Carlos; Lage, Maria Lucia; Franceschi, Giulia; Lucena, Rita] Univ Fed Bahia, Salvador, BA, Brazil.
   [Mochida, Ganeshwaran] Boston Childrens Hosp, Boston, MA USA.
   [Mochida, Ganeshwaran] Harvard Med Sch, Boston, MA 02115 USA.
   [Mochida, Ganeshwaran] Massachusetts Gen Hosp, Boston, MA 02114 USA.
   [Lucena, Pedro] Bahiana Sch Med & Publ Hlth, Salvador, BA, Brazil.
RP Carvalho, A (corresponding author), SARAH Salvador Hosp, Av Tancredo Neves 2782, BR-41820900 Salvador, BA, Brazil.
EM 13110@sarah.br
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Lucena, Pedro/0000-0003-1148-7806;
   Mochida, Ganeshwaran/0000-0001-7912-4097
CR Abramov DM, 2018, NEUROLOGY, V90, pE606, DOI 10.1212/WNL.0000000000004974
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   BLECK EE, 1975, DEV MED CHILD NEUROL, V17, P18
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2018, B EPIDEMIOLOGICO, V49, P1
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Petribu NCD, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4188
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Granild-Jensen JB, 2015, DEV MED CHILD NEUROL, V57, P931, DOI 10.1111/dmcn.12760
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lustig Y, 2018, J CLIN VIROL, V99-100, P31, DOI 10.1016/j.jcv.2017.12.007
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x
   Pan American Health Organization World Health Organization, 2016, NEUR SYNDR CONG AN Z, V8
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rodo C, 2017, CLIN MICROBIOL INFEC, V24, P2017
   Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x
   Rosman NP, 2011, PEDIATRICS, V127, P665, DOI 10.1542/peds.2010-1576
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 35
TC 12
Z9 12
U1 2
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0387-7604
EI 1872-7131
J9 BRAIN DEV-JPN
JI Brain Dev.
PD AUG
PY 2019
VL 41
IS 7
BP 587
EP 594
DI 10.1016/j.braindev.2019.03.005
PG 8
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA IY1EA
UT WOS:000486133200003
PM 30914212
DA 2020-12-15
ER

PT J
AU Barretto, TL
   Bandeira, ID
   Jagersbacher, JG
   Barretto, BL
   Torres, AFSDE
   Pena, N
   Miranda, JGV
   Lucena, R
AF Barretto, Thiago Lima
   Bandeira, Igor Dorea
   Jagersbacher, Joao Gabriel
   Barretto, Bianca Lima
   Souza de Oliveira e Torres, Angelo Frederico
   Pena, Norberto
   Vivas Miranda, Jose Garcia
   Lucena, Rita
TI Transcranial direct current stimulation in the treatment of cerebellar
   ataxia: A two-phase, double-blind, auto-matched, pilot study
SO CLINICAL NEUROLOGY AND NEUROSURGERY
LA English
DT Article
DE Cerebellar ataxia; Transcranial direct current stimulation; tDCS;
   Neuromodulation; Clinical trial; Noninvasive brain stimulation;
   Cerebellum; SARA
ID MOTOR CORTEX; DC STIMULATION; SCALE; TDCS; EXCITABILITY; VARIABILITY;
   TRIAL
AB Objective: To assess the impact of tDCS on posture, gait and coordination of movements in subjects with cerebellar ataxia.
   Patients and methods: This is a two-phase, double blind, auto matched, pilot study. Seven people were selected to participate in the study aged from 14 to 57. tDCS and sham-tDCS were applied at different times to all participants for 40 min over five consecutive days so that they were blind to which of the two techniques was applied at any one time. The area stimulated was the bilateral motor cortex. Subjects were evaluated before and after the interventions using the Scale for Assessment and Rating of Ataxia (SARA) and specific tests to measure posture and balance were carried out using the Wii Fit platform and CvMob software.
   Results: The study indicates a statistically significant improvement in respect of gait parameters and the total score of the SARA scale and Wii Fit platform after tDCS when compared with data obtained from sham-tDCS trials (p: 0,03). The adverse events relating to tDCS were all self-limiting and from mild to moderate intensity.
   Conclusion: Despite the small sample size, tDCS showed positive results in some motor parameters and could be considered a valuable new option for the treatment of cerebellar ataxias.
C1 [Barretto, Thiago Lima; Jagersbacher, Joao Gabriel; Barretto, Bianca Lima] Univ Fed Bahia, Med Sch Bahia, Dept Neurosci & Mental Hlth, Salvador, BA, Brazil.
   [Bandeira, Igor Dorea] Univ Fed Bahia, Med Sch Bahia, Dept Neurosci & Mental Hlth, Salvador, BA, Brazil.
   [Souza de Oliveira e Torres, Angelo Frederico; Vivas Miranda, Jose Garcia] Univ Fed Bahia, Inst Phys, Salvador, BA, Brazil.
   [Pena, Norberto] Univ Fed Bahia, Fac Hlth Sci, Dept Physiotherapy, Salvador, BA, Brazil.
   [Lucena, Rita] Univ Fed Bahia, Med Sch Bahia, Dept Neurosci & Mental Hlth, Salvador, BA, Brazil.
RP Lucena, R (corresponding author), Praca XV Novembro,S-N Largo Terreiro de Jesus, BR-40025010 Salvador, BA, Brazil.
EM rcslucena@yahoo.com.br
RI Lucena, Rita/L-9842-2013; Bandeira, Igor Dorea/J-8835-2015
OI Lucena, Rita/0000-0002-6190-9168; Bandeira, Igor
   Dorea/0000-0002-6714-2658
CR Andrade AC, 2014, J CHILD NEUROL, V29, P1360, DOI 10.1177/0883073813503710
   Ardolino G, 2005, J PHYSIOL-LONDON, V568, P653, DOI 10.1113/jphysiol.2005.088310
   Bandeira ID, 2016, J CHILD NEUROL, V31, P918, DOI 10.1177/0883073816630083
   Ben Taib Nordeyn Oulad, 2009, J Neurosurg, V111, P796, DOI 10.3171/2008.2.17679
   Benussi A, 2015, MOVEMENT DISORD, V30, P1701, DOI 10.1002/mds.26356
   Braga-Neto P, 2010, ARQ NEURO-PSIQUIAT, V68, P228, DOI 10.1590/S0004-282X2010000200014
   Brunoni AR, 2017, NEW ENGL J MED, V376, P2523, DOI 10.1056/NEJMoa1612999
   Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690
   Brusse E, 2007, CLIN GENET, V71, P12, DOI 10.1111/j.1399-0004.2006.00722.x
   Chalah MA, 2017, J NEUROL SCI, V372, P131, DOI 10.1016/j.jns.2016.11.015
   Chew T, 2015, BRAIN STIMUL, V8, P1130, DOI 10.1016/j.brs.2015.07.031
   dos Santos VS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30127-z
   Ferrucci R, 2014, NEUROIMAGE, V85, P918, DOI 10.1016/j.neuroimage.2013.04.122
   Gagnon C, 2018, NEUROLOGY, V91, pE1307, DOI 10.1212/WNL.0000000000006290
   Galea JM, 2009, J NEUROSCI, V29, P9115, DOI 10.1523/JNEUROSCI.2184-09.2009
   Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003
   Grimaldi G, 2014, CEREBELLUM, V13, P121, DOI 10.1007/s12311-013-0514-7
   Grimaldi G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00009
   Grimaldi G, 2013, ANN BIOMED ENG, V41, P2437, DOI 10.1007/s10439-013-0846-y
   Groiss SJ, 2012, CEREBELLUM, V11, P440, DOI 10.1007/s12311-011-0329-3
   Ho KA, 2016, BRAIN STIMUL, V9, P1, DOI 10.1016/j.brs.2015.08.003
   HORE J, 1988, J NEUROPHYSIOL, V60, P1285
   Laakso I, 2015, BRAIN STIMUL, V8, P906, DOI 10.1016/j.brs.2015.05.002
   Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x
   Liepert J, 2004, STROKE, V35, P2484, DOI 10.1161/01.STR.0000143152.45801.ca
   Lopez-Bastida J, 2008, MOVEMENT DISORD, V23, P212, DOI 10.1002/mds.21798
   Manto MU, 2005, CEREBELLUM, V4, P2, DOI 10.1080/14734220510007914
   Marsden J, 2011, CLIN REHABIL, V25, P195, DOI 10.1177/0269215510382495
   Matsushima Akira, 2015, Cerebellum Ataxias, V2, P9, DOI 10.1186/s40673-015-0028-9
   Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x
   Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47
   Palm U, 2016, RESTOR NEUROL NEUROS, V34, P189, DOI 10.3233/RNN-150557
   Parazzini M, 2014, CLIN NEUROPHYSIOL, V125, P577, DOI 10.1016/j.clinph.2013.09.039
   Park DS, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-99
   Pena N, 2013, REV BRAS ENSINO FIS, V35, DOI 10.1590/S1806-11172013000300024
   Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004
   Pozzi NG, 2014, CEREBELLUM, V13, P109, DOI 10.1007/s12311-013-0524-5
   Quixada A.P., 2016, ARXIV160204513
   Rios DM, 2018, CHILD NEUROL OPEN, V5
   Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92
   Schmitz-Hubsch T, 2010, MOVEMENT DISORD, V25, P587, DOI 10.1002/mds.22740
   Wang RY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26109-w
   Weyer A, 2007, MOVEMENT DISORD, V22, P1633, DOI 10.1002/mds.21544
   Yabe I, 2008, J NEUROL SCI, V266, P164, DOI 10.1016/j.jns.2007.09.021
NR 44
TC 5
Z9 5
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0303-8467
EI 1872-6968
J9 CLIN NEUROL NEUROSUR
JI Clin. Neurol. Neurosurg.
PD JUL
PY 2019
VL 182
BP 123
EP 129
DI 10.1016/j.clineuro.2019.05.009
PG 7
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA IF1BT
UT WOS:000472812800024
PM 31121471
DA 2020-12-15
ER

PT J
AU Carvalho, AL
   Brandi, IV
   Sarmento, M
   Brites, C
   Lucena, R
AF Carvalho, A. L.
   Brandi, I. V.
   Sarmento, M.
   Brites, C.
   Lucena, R.
TI Difficulties with laboratory confirmation of congenital Zika virus
   infection in a tertiary hospital in Northeastern Brazil
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Letter
C1 [Carvalho, A. L.; Brandi, I. V.; Sarmento, M.] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Brites, C.; Lucena, R.] Univ Fed Bahia, Salvador, BA, Brazil.
RP Carvalho, AL (corresponding author), SARAH Salvador Hosp, Ave Tancredo Neves,2782 Caminho Arvores, BR-41820900 Salvador, BA, Brazil.
EM alessandracarvalhoped@gmail.com
RI Brites, Carlos/D-1353-2013; Lucena, Rita/L-9842-2013
OI Brites, Carlos/0000-0002-4673-6991; Lucena, Rita/0000-0002-6190-9168
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rodo C, 2017, CLIN MICROBIOL INFEC, V24, P2017
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
NR 6
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD APR
PY 2019
VL 25
IS 4
BP 524
EP 525
DI 10.1016/j.cmi.2018.12.021
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA HR9LL
UT WOS:000463481300031
PM 30583057
OA Bronze
DA 2020-12-15
ER

PT J
AU de Carvalho, AL
   Brites, C
   Taguchi, TB
   Pinho, SF
   Campos, G
   Lucena, R
AF de Carvalho, Alessandra Lemos
   Brites, Carlos
   Taguchi, Tania Barreto
   Pinho, Suely Fernandes
   Campos, Gubio
   Lucena, Rita
TI Congenital Zika Virus Infection with Normal Neurodevelopmental Outcome,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB We describe a case of a 20-month-old girl with probable congenital Zika virus infection and normal neurodevelopment, despite microcephaly and abnormal neuroimaging. This case raises questions about early prognostic markers and draws attention to the need for investigation in suspected Zika cases, even if the child's early neurodevelopment is normal.
C1 [de Carvalho, Alessandra Lemos] SARAH Network Rehabil Hosp, Child Rehabil Ctr, Salvador Unit, Salvador, BA, Brazil.
   [Taguchi, Tania Barreto; Pinho, Suely Fernandes] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Brites, Carlos; Campos, Gubio; Lucena, Rita] Univ Fed Bahia, Salvador, BA, Brazil.
RP de Carvalho, AL (corresponding author), SARAH Salvador Hosp, Av Tancredo Neves 2782, BR-41820900 Salvador, BA, Brazil.
EM alessandracarvalhoped@gmail.com
RI Brites, Carlos/D-1353-2013; Lucena, Rita/L-9842-2013
OI Brites, Carlos/0000-0002-4673-6991; Lucena, Rita/0000-0002-6190-9168
FU Coordination for the Improvement of Higher Education Personnel (CAPES),
   BrazilCAPES
FX No external funding was used for this study. G.C. received a "Zika fast
   track grant" provided by Coordination for the Improvement of Higher
   Education Personnel (CAPES), Brazil, to perform ELISA testing for Zika
   virus in the neonatal period. This institution had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of this manuscript. The other authors have no financial
   disclosures relevant to this article.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bayley N., 2005, BAYLEY SCALES INFANT
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097]
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA
NR 10
TC 2
Z9 2
U1 0
U2 5
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2018
VL 24
IS 11
BP 2128
EP 2130
DI 10.3201/eid2411.180883
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GX4UO
UT WOS:000447732600037
PM 30334734
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Lopes, TD
   Silva, WD
   Ribeiro, SB
   Figueiredo, CA
   Campbell, FQ
   Daltro, GD
   Valenzuela, A
   Montoya, P
   Lucena, RDS
   Baptista, AF
AF Lopes, Tiago da Silva
   Silva, Wellington dos Santos
   Ribeiro, Sanzia B.
   Figueiredo, Camila A.
   Campbell, Fernanda Q.
   Daltro, Gildasio de Cerqueira
   Valenzuela, Antonio
   Montoya, Pedro
   Lucena, Rita de C. S.
   Baptista, Abrahao F.
TI Does Transcranial Direct Current Stimulation Combined with Peripheral
   Electrical Stimulation Have an Additive Effect in the Control of Hip
   Joint Osteonecrosis Pain Associated with Sickle Cell Disease? A Protocol
   for a One-Session Double Blind, Block-Randomized Clinical Trial
SO FRONTIERS IN HUMAN NEUROSCIENCE
LA English
DT Article
DE neuromodulation; electroencephalography; sickle cell disease; BDNF; TNF;
   tDCS; peripheral electrical stimulation
ID LOW-BACK-PAIN; HUMAN MOTOR CORTEX; PRIMARY AFFERENT TERMINALS;
   SPINAL-CORD-INJURY; NEUROTROPHIC FACTOR; NEUROPATHIC PAIN; FEMORAL-HEAD;
   CORTICOSPINAL EXCITABILITY; PSYCHOMETRIC PROPERTIES; CENTRAL
   SENSITIZATION
AB Chronic pain in Sickle Cell Disease (SCD) is probably related to maladaptive plasticity of brain areas involved in nociceptive processing. Transcranial Direct Current Stimulation (tDCS) and Peripheral Electrical Stimulation (PES) can modulate cortical excitability and help to control chronic pain. Studies have shown that combined use of tDCS and PES has additive effects. However, to date, no study investigated additive effects of these neuromodulatory techniques on chronic pain in patients with SCD. This protocol describes a study aiming to assess whether combined use of tDCS and PES more effectively alleviate pain in patients with SCD compared to single use of each technique. The study consists of a one-session double blind, block-randomized clinical trial (NCT02813629) in which 128 participants with SCD and femoral osteonecrosis will be enrolled. Stepwise procedures will occur on two independent days. On day 1, participants will be screened for eligibility criteria. On day 2, data collection will occur in four stages: sample characterization, baseline assessment, intervention, and post-intervention assessment. These procedures will last similar to 5 h. Participants will be divided into two groups according to homozygous for S allele (HbSS) (n = 64) and heterozygous for S and C alleles (HbSC) (n = 64) genotypes. Participants in each group will be randomly assigned, equally, to one of the following interventions: (1) active tDCS + active PES; (2) active tDCS + sham PES; (3) sham tDCS + active PES; and (4) sham tDCS + sham PES. Active tDCS intervention will consist of 20min 2mA anodic stimulation over the primary motor cortex contralateral to the most painful hip. Active PES intervention will consist of 30min sensory electrical stimulation at 100Hz over the most painful hip. The main study outcome will be pain intensity, measured by a Visual Analogue Scale. In addition, electroencephalographic power density, cortical maps of the gluteus maximus muscle elicited by Transcranial Magnetic Stimulation (TMS), serum levels of Brain- derived Neurotrophic Factor (BDNF), and Tumor Necrosis Factor (TNF) will be assessed as secondary outcomes. Data will be analyzed using ANOVA of repeated measures, controlling for confounding variables.
C1 [Lopes, Tiago da Silva; Silva, Wellington dos Santos; Ribeiro, Sanzia B.; Campbell, Fernanda Q.; Lucena, Rita de C. S.; Baptista, Abrahao F.] Univ Fed Bahia, Hlth & Funct Study Grp, Salvador, BA, Brazil.
   [Lopes, Tiago da Silva; Silva, Wellington dos Santos; Lucena, Rita de C. S.; Baptista, Abrahao F.] Univ Fed Bahia, Grad Program Med & Hlth, Salvador, BA, Brazil.
   [Silva, Wellington dos Santos; Ribeiro, Sanzia B.] Adventist Fac Bahia, Hlth Sect, Cachoeira, Brazil.
   [Figueiredo, Camila A.] Univ Fed Bahia, Dept Bioregulat, Salvador, BA, Brazil.
   [Daltro, Gildasio de Cerqueira] Complexo Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.
   [Valenzuela, Antonio] Loma Linda Univ, Phys Therapy, Loma Linda, CA 92350 USA.
   [Montoya, Pedro] Univ Balearic Isl, Res Inst Hlth Sci IUNICS, Palma De Mallorca, Spain.
   [Baptista, Abrahao F.] Fed Univ ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo, Brazil.
RP Baptista, AF (corresponding author), Univ Fed Bahia, Hlth & Funct Study Grp, Salvador, BA, Brazil.; Baptista, AF (corresponding author), Univ Fed Bahia, Grad Program Med & Hlth, Salvador, BA, Brazil.; Baptista, AF (corresponding author), Fed Univ ABC, Ctr Math Computat & Cognit, Sao Bernardo Do Campo, Brazil.
EM a.baptista@ufabc.edu.br
RI Montoya, Pedro/A-4666-2009; Lucena, Rita/L-9842-2013; Figueiredo,
   Camila/H-3525-2015
OI Montoya, Pedro/0000-0001-8652-948X; Lucena, Rita/0000-0002-6190-9168;
   Figueiredo, Camila/0000-0003-1356-6188; Lopes, Tiago/0000-0001-8280-240X
FU Research Support Foundation of the State of Bahia (FAPESB) through the
   Support Program for Emerging Center [8133/2014 (PNE0020/2014)];
   Coordination for the Improvement of Higher Education Personnel
   (CAPES)CAPES
FX This study is funded by the Research Support Foundation of the State of
   Bahia (FAPESB) through the Support Program for Emerging Center,
   8133/2014 (PNE0020/2014). The first author is supported by a MSc
   scholarship from the Coordination for the Improvement of Higher
   Education Personnel (CAPES).
CR Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093
   Andrade DC, 2013, EXPERT REV MED DEVIC, V10, P339, DOI [10.1586/erd.12.90, 10.1586/ERD.12.90]
   Antal A, 2010, BRAIN STIMUL, V3, P230, DOI 10.1016/j.brs.2009.12.003
   Bakshi N, 2017, J PAIN, V18, P1216, DOI 10.1016/j.jpain.2017.05.005
   Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133
   Ballas SK, 2015, EUR J HAEMATOL, V95, P113, DOI 10.1111/ejh.12460
   Ballas SK, 2012, SCI WORLD J, DOI 10.1100/2012/949535
   Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008
   Barakat LP, 2010, J PEDIAT HEMATOL ONC, V32, P540, DOI 10.1097/MPH.0b013e3181e793f9
   Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116
   Begliuomini S, 2008, J ENDOCRINOL, V197, P429, DOI 10.1677/JOE-07-0376
   Biggs JE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-44
   Boggio PS, 2009, CLIN J PAIN, V25, P691, DOI 10.1097/AJP.0b013e3181af1414
   Bolognini N, 2015, J PAIN, V16, P657, DOI 10.1016/j.jpain.2015.03.013
   Campbell CM, 2016, J PAIN, V17, P617, DOI 10.1016/j.jpain.2016.01.475
   Caracas MD, 2013, OR SURG OR MED OR PA, V115, pE31, DOI 10.1016/j.oooo.2012.05.018
   Case M, 2017, NEUROIMAGE-CLIN, V14, P1, DOI 10.1016/j.nicl.2016.12.024
   Caumo W, 2017, J PAIN RES, V10, P2109, DOI 10.2147/JPR.S131479
   Caumo W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00357
   Chen WL, 2014, EUR J NEUROSCI, V39, P1439, DOI 10.1111/ejn.12516
   Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025
   Chipchase LS, 2011, ARCH PHYS MED REHAB, V92, P1423, DOI 10.1016/j.apmr.2011.01.011
   Cioato SG, 2016, BRAIN STIMUL, V9, P209, DOI 10.1016/j.brs.2015.12.001
   Cohen JF, 1977, STATISTICAL POWER AN, P273
   Coutaux A, 2017, JOINT BONE SPINE, V84, P657, DOI 10.1016/j.jbspin.2017.02.005
   Darbari DS, 2015, J PAIN, V16, P1077, DOI 10.1016/j.jpain.2015.07.005
   Di Lazzaro V, 2015, BRAIN STIMUL, V8, P92, DOI 10.1016/j.brs.2014.08.006
   Pinheiro ESD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149085
   Duncan R, 2007, ANN RHEUM DIS, V66, P86, DOI 10.1136/ard.2006.052548
   Ejindu VC, 2007, RADIOGRAPHICS, V27, P1005, DOI 10.1148/rg.274065142
   Ezquerro F, 2017, NEUROMODULATION, V20, P248, DOI 10.1111/ner.12527
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3
   Fisher BE, 2013, J ORTHOP SPORT PHYS, V43, P214, DOI 10.2519/jospt.2013.4188
   Flouzat-Lachaniette CH, 2016, INT ORTHOP, V40, P669, DOI 10.1007/s00264-015-3060-8
   Grimsholm O, 2008, CLIN RHEUMATOL, V27, P1289, DOI 10.1007/s10067-008-0910-4
   Hazime FA, 2017, EUR J PAIN, V21, P1132, DOI 10.1002/ejp.1037
   Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455
   Jacobson L, 2012, CLIN NEUROPHYSIOL, V123, P979, DOI 10.1016/j.clinph.2011.09.016
   JANG S, 2016, C P IEEE ENG MED BIO, P5258, DOI DOI 10.1109/EMBC.2016.7591913
   Kang M, 2008, J ATHL TRAINING, V43, P215, DOI 10.4085/1062-6050-43.2.215
   Keefe FJ, 2004, J PAIN, V5, P195, DOI 10.1016/j.jpain.2004.02.576
   Keeser D, 2011, NEUROIMAGE, V55, P644, DOI 10.1016/j.neuroimage.2010.12.004
   Kuner R, 2017, NAT REV NEUROSCI, V18, P20, DOI 10.1038/nrn.2016.162
   Lepley AS, 2013, J SPORT REHABIL, V22, P239, DOI 10.1123/jsr.22.4.239
   Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222
   Luedtke K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1640
   Luedtke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048857
   Malouin Francine, 2007, J Neurol Phys Ther, V31, P20
   Marques PR, 2016, PROG NEURO-PSYCHOPH, V64, P44, DOI 10.1016/j.pnpbp.2015.06.016
   McDonnell MN, 2007, NEUROREHAB NEURAL RE, V21, P435, DOI 10.1177/1545968307300437
   McKay D, 2002, NEUROREPORT, V13, P1271, DOI 10.1097/00001756-200207190-00011
   Mendonca ME, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00068
   Meneses FM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00395
   Merighi A, 2008, DEV NEUROBIOL, V68, P457, DOI 10.1002/dneu.20605
   MILNER PF, 1991, NEW ENGL J MED, V325, P1476, DOI 10.1056/NEJM199111213252104
   Muller-Dahlhaus F, 2015, NEUROSCIENTIST, V21, P185, DOI 10.1177/1073858414526645
   New T, 2014, J PEDIAT HEMATOL ONC, V36, pE398, DOI 10.1097/MPH.0000000000000026
   Ngernyam N, 2015, CLIN NEUROPHYSIOL, V126, P382, DOI 10.1016/j.clinph.2014.05.034
   Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899
   Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x
   Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618
   Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004
   O'Connell NE, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008208.pub3
   Pais-Ribeiro J, 2007, Psychol Health Med, V12, P225, DOI 10.1080/13548500500524088
   Pan WH, 2002, J APPL PHYSIOL, V92, P1357, DOI 10.1152/japplphysiol.00915.2001
   Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379
   Parker RS, 2016, BRAIN STIMUL, V9, P488, DOI 10.1016/j.brs.2016.03.020
   Petroianu Andy, 2010, Arch. Clin. Psychiatry (São Paulo), V37, P1, DOI 10.1590/S0101-60832010000100001
   PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303
   Polania R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030971
   Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004
   Rakel B, 2010, J PAIN, V11, P230, DOI 10.1016/j.jpain.2009.07.007
   Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X
   Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016
   Sakrajai P, 2014, CLIN J PAIN, V30, P1076, DOI 10.1097/AJP.0000000000000069
   Santos JG, 2010, J PAIN, V11, P484, DOI 10.1016/j.jpain.2009.09.014
   Schabrun SM, 2015, MED SCI SPORT EXER, V47, P681, DOI 10.1249/MSS.0000000000000469
   Schabrun SM, 2014, BRAIN STIMUL, V7, P451, DOI 10.1016/j.brs.2014.01.058
   Schabrun SM, 2013, BRAIN STIMUL, V6, P624, DOI 10.1016/j.brs.2012.09.009
   Schabrun SM, 2012, MANUAL THER, V17, P184, DOI 10.1016/j.math.2011.12.001
   Schulte-Herbruggen O, 2005, J NEUROIMMUNOL, V160, P204, DOI 10.1016/j.jneuroim.2004.10.026
   Simao AP, 2014, RHEUMATOL INT, V34, P1153, DOI 10.1007/s00296-013-2943-5
   Adachi LNS, 2015, EXP BRAIN RES, V233, P1377, DOI 10.1007/s00221-015-4212-1
   TAIT RC, 1990, PAIN, V40, P171, DOI 10.1016/0304-3959(90)90068-O
   Te M, 2017, PAIN MED, V18, P2224, DOI 10.1093/pm/pnx036
   Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154
   Tsao H, 2011, SPINE, V36, P1721, DOI 10.1097/BRS.0b013e31821c4267
   Vaseghi B, 2014, CLIN NEUROPHYSIOL, V125, P1847, DOI 10.1016/j.clinph.2014.01.020
   Vaseghi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123873
   Walton KD, 2010, PAIN, V150, P41, DOI 10.1016/j.pain.2010.02.023
   Williams H, 2016, J PAIN SYMPTOM MANAG, V51, P163, DOI 10.1016/j.jpainsymman.2015.10.017
   Wrigley PJ, 2013, PAIN, V154, P2178, DOI 10.1016/j.pain.2013.06.045
   Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517
NR 94
TC 0
Z9 0
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5161
J9 FRONT HUM NEUROSCI
JI Front. Hum. Neurosci.
PD DEC 20
PY 2017
VL 11
AR 633
DI 10.3389/fnhum.2017.00633
PG 12
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA FQ4MR
UT WOS:000418332100001
PM 29326577
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Bandeira, ID
   Jagersbacher, JG
   Barretto, TL
   Santos, CV
   Lucena, R
AF Bandeira, Igor Dorea
   Jagersbacher, Joao Gabriel
   Barretto, Thiago Lima
   Santos, Camilo Vieira
   Lucena, Rita
TI BOTULINUM TOXIN TYPE A IN THE TREATMENT OF FACIAL MYOTONIA IN
   SCHWARTZ-JAMPEL SYNDROME
SO MUSCLE & NERVE
LA English
DT Editorial Material
DE botulinum toxin type A; facial myotonia; myotonia; rehabilitation;
   Schwartz-Jampel syndrome
ID BLEPHAROSPASM; INJECTIONS; PERLECAN
C1 [Bandeira, Igor Dorea; Jagersbacher, Joao Gabriel; Barretto, Thiago Lima; Lucena, Rita] Univ Fed Bahia, Med Sch Bahia, Dept Neurosci & Mental Hlth, Praca 15 Novembro S-N, BR-40025010 Salvador, BA, Brazil.
   [Santos, Camilo Vieira] Univ Fed Bahia, Prof Edgard Santos Univ Hosp, Salvador, BA, Brazil.
RP Bandeira, ID (corresponding author), Univ Fed Bahia, Med Sch Bahia, Dept Neurosci & Mental Hlth, Praca 15 Novembro S-N, BR-40025010 Salvador, BA, Brazil.
EM igordbandeira@gmail.com
RI Lucena, Rita/L-9842-2013; Bandeira, Igor Dorea/J-8835-2015
OI Lucena, Rita/0000-0002-6190-9168; Bandeira, Igor
   Dorea/0000-0002-6714-2658
CR Aberfeld D, 1970, ARCH NEUROL-CHICAGO, V22, P7
   Aburahma SK, 2009, J CHILD NEUROL, V24, P5, DOI 10.1177/0883073808320621
   Arikawa-Hirasawa E, 2002, AM J HUM GENET, V70, P1368, DOI 10.1086/340390
   Brown KA, 1997, J MED GENET, V34, P3
   Echaniz-Laguna A, 2009, MUSCLE NERVE, V40, P55, DOI 10.1002/mus.21253
   Kashkouli MB, OPHTHALMIC IN PRESS
   Kim HJ, 2002, AUTON NEUROSCI-BASIC, V102, P8, DOI 10.1016/S1566-0702(02)00093-0
   Morrison DA, 2006, OPHTHAL PLAST RECONS, V22, P57, DOI 10.1097/01.iop.0000195008.15872.a0
   Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638
   Vargel I, 2006, J CRANIOFAC SURG, V17, P656, DOI 10.1097/00001665-200607000-00008
NR 10
TC 2
Z9 2
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0148-639X
EI 1097-4598
J9 MUSCLE NERVE
JI Muscle Nerve
PD AUG
PY 2017
VL 56
IS 2
BP E10
EP E11
DI 10.1002/mus.25610
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA FC5IL
UT WOS:000406875000002
PM 28187499
DA 2020-12-15
ER

PT J
AU Bandeira, ID
   Guimaraes, RSQ
   Jagersbacher, JG
   Barretto, TL
   de Jesus-Silva, JR
   Santos, SN
   Argollo, N
   Lucena, R
AF Bandeira, Igor Dorea
   Quadros Guimaraes, Rachel Silvany
   Jagersbacher, Joao Gabriel
   Barretto, Thiago Lima
   de Jesus-Silva, Jessica Regina
   Santos, Samantha Nunes
   Argollo, Nayara
   Lucena, Rita
TI Transcranial Direct Current Stimulation in Children and Adolescents With
   Attention-Deficit/Hyperactivity Disorder (ADHD): A Pilot Study
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE attention-deficit hyperactivity disorder (ADHD); transcranial direct
   current stimulation; dorsolateral prefrontal cortex; noninvasive brain
   stimulation; neuromodulation
ID DEFICIT-HYPERACTIVITY-DISORDER; NONINVASIVE BRAIN-STIMULATION;
   YOUNG-PEOPLE; IMPROVEMENT; PREVALENCE; GUIDELINES; DIAGNOSIS; DECLINE;
   ADULTS
AB Studies investigating the possible benefits of transcranial direct current stimulation on left dorsolateral prefrontal cortex in children and adolescents with attention-deficit hyperactivity disorder (ADHD) have not been performed. This study assesses the effect of transcranial direct current stimulation in children and adolescents with ADHD on neuropsychological tests of visual attention, visual and verbal working memory, and inhibitory control. An auto-matched clinical trial was performed involving transcranial direct current stimulation in children and adolescents with ADHD, using SNAP-IV and subtests Vocabulary and Cubes of the Wechsler Intelligence Scale for Children III (WISC-III). Subjects were assessed before and after transcranial direct current stimulation sessions with the Digit Span subtest of the WISC-III, inhibitory control subtest of the NEPSY-II, Corsi cubes, and the Visual Attention Test (TAVIS-3). There were 9 individuals with ADHD according to Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) criteria. There was statistically significant difference in some aspects of TAVIS-3 tests and the inhibitory control subtest of NEPSY-II. Transcranial direct current stimulation can be related to a more efficient processing speed, improved detection of stimuli, and improved ability to switch between an ongoing activity and a new one.
C1 [Bandeira, Igor Dorea; Quadros Guimaraes, Rachel Silvany; Jagersbacher, Joao Gabriel; Barretto, Thiago Lima; de Jesus-Silva, Jessica Regina; Lucena, Rita] Univ Fed Bahia, Med Sch Bahia, Dept Neurosci & Mental Hlth, Praca 15 Novembro,S-N Largo Terreiro de Jesus, BR-40025 Salvador, BA, Brazil.
   [Santos, Samantha Nunes] Univ Fed Bahia, Prof Edgard Santos Univ Teaching Hosp, BR-40025 Salvador, BA, Brazil.
   [Argollo, Nayara] Univ Fed Bahia, Med Sch Bahia, Dept Pediat, BR-40025 Salvador, BA, Brazil.
RP Bandeira, ID (corresponding author), Univ Fed Bahia, Med Sch Bahia, Dept Neurosci & Mental Hlth, Praca 15 Novembro,S-N Largo Terreiro de Jesus, BR-40025 Salvador, BA, Brazil.
EM igordbandeira@gmail.com
RI Bandeira, Igor Dorea/J-8835-2015; Lucena, Rita/L-9842-2013
OI Bandeira, Igor Dorea/0000-0002-6714-2658; Lucena,
   Rita/0000-0002-6190-9168
CR Andrade AC, 2014, J CHILD NEUROL, V29, P1360, DOI 10.1177/0883073813503710
   Arnold LE, 2015, J ATTEN DISORD, P1
   Asherson Philip, 2005, Expert Rev Neurother, V5, P525, DOI 10.1586/14737175.5.4.525
   Baker JM, 2010, STROKE, V41, P1229, DOI 10.1161/STROKEAHA.109.576785
   Barbaresi W, 2002, ARCH PEDIAT ADOL MED, V156, P217, DOI 10.1001/archpedi.156.3.217
   Batista EK, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv066
   Boggio PS, 2007, J AFFECT DISORDERS, V101, P91, DOI 10.1016/j.jad.2006.10.026
   Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690
   Bunse T, 2014, BRAIN STIMUL, V7, P158, DOI 10.1016/j.brs.2013.08.009
   Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034
   Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120
   Cheung CHM, 2015, J PSYCHIATR RES, V62, P92, DOI 10.1016/j.jpsychires.2015.01.011
   Cosmo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135371
   Demirtas-Tatlidede A, 2013, NEUROPHARMACOLOGY, V64, P566, DOI 10.1016/j.neuropharm.2012.06.020
   Faraone SV, 2006, PSYCHOL MED, V36, P159, DOI 10.1017/S003329170500471X
   Graham J, 2011, EUR CHILD ADOLES PSY, V20, P17, DOI 10.1007/s00787-010-0140-6
   Harpin VA, 2005, ARCH DIS CHILD, V90, pI2, DOI 10.1136/adc.2004.059006
   Kang EK, 2009, RESTOR NEUROL NEUROS, V27, P645, DOI 10.3233/RNN-2009-0514
   Kendall T, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1239
   Kieling C, 2008, CHILD ADOL PSYCH CL, V17, P285, DOI 10.1016/j.chc.2007.11.012
   Kim B, 2015, J ATTEN DISORD, P5
   Kooij JJS, 2005, PSYCHOL MED, V35, P817, DOI 10.1017/S003329170400337X
   Kooij SJJ, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-67
   Koops S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00244
   Krause B, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00025
   Krause B, 2013, DEV COGN NEUROS-NETH, V6, P176, DOI 10.1016/j.dcn.2013.04.001
   Krishnan C, 2015, BRAIN STIMUL, V8, P76, DOI 10.1016/j.brs.2014.10.012
   Langley K, 2010, BRIT J PSYCHIAT, V196, P235, DOI 10.1192/bjp.bp.109.066274
   Loftus AM, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.332
   Lu CB, 2015, NEUROMODULATION, V18, P442, DOI 10.1111/ner.12302
   Mannuzza S, 2000, CHILD ADOL PSYCH CL, V9, P711
   Muller-Dahlhaus F, 2015, NEUROSCIENTIST, V21, P185, DOI 10.1177/1073858414526645
   Narad ME, 2015, J ATTEN DISORD, P3
   Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004
   Nowak DA, 2009, NEUROREHAB NEURAL RE, V23, P641, DOI 10.1177/1545968309336661
   Oliveira JF, 2013, NEUROSCI LETT, V537, P60, DOI 10.1016/j.neulet.2013.01.023
   Pereira Junior Bde S., 2015, NEURAL PLAST, V2015
   Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942
   Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261
   Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314
   Saba G, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0571-3
   Spieser L, 2015, J NEUROSCI, V35, P3010, DOI 10.1523/JNEUROSCI.1642-14.2015
   Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026
   Val-Laillet D, 2015, NEUROIMAGE-CLIN, V8, P1, DOI 10.1016/j.nicl.2015.03.016
NR 44
TC 35
Z9 39
U1 2
U2 20
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD JUN
PY 2016
VL 31
IS 7
BP 918
EP 924
DI 10.1177/0883073816630083
PG 7
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA DM3RU
UT WOS:000376264800017
PM 26879095
DA 2020-12-15
ER

PT J
AU Lucena, R
   Thompson, C
AF Lucena, R.
   Thompson, C.
TI BALANCE AND STRENGTH TRAINING IN OLDER ADULTS: IMPACT OF A SIX-WEEK
   INTERVENTION ON BALANCE RELATED MEASURES
SO GERONTOLOGIST
LA English
DT Meeting Abstract
C1 [Lucena, R.; Thompson, C.] Univ W Florida, Pensacola, FL 32514 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0016-9013
EI 1758-5341
J9 GERONTOLOGIST
JI Gerontologist
PD NOV
PY 2014
VL 54
SU 2
BP 86
EP 87
PG 2
WC Gerontology
SC Geriatrics & Gerontology
GA AW5TU
UT WOS:000346337501119
DA 2020-12-15
ER

PT J
AU Andrade, AC
   Magnavita, GM
   Allegro, JVBN
   Neto, CEBP
   Lucena, RDS
   Fregni, F
AF Andrade, Agnes Carvalho
   Magnavita, Guilherme Moreira
   Brasil Nunes Allegro, Juleilda Valeria
   Borges Passos Neto, Carlos Eduardo
   Saldanha Lucena, Rita de Cassia
   Fregni, Felipe
TI Feasibility of Transcranial Direct Current Stimulation Use in Children
   Aged 5 to 12 Years
SO JOURNAL OF CHILD NEUROLOGY
LA English
DT Article
DE tDCS; brain stimulation; language disorders
ID NONINVASIVE BRAIN-STIMULATION; MAGNETIC STIMULATION; SAFETY; RTMS
AB Transcranial direct current stimulation is a noninvasive brain stimulation technique that has been studied for the treatment of neuropsychiatric disorders in adults, with minimal side effects. The objective of this study is to report the feasibility, tolerability, and the short-term adverse effects of transcranial direct current stimulation in children from 5 to 12 years of age. It is a naturalistic study of 14 children who underwent 10 sessions of transcranial direct current stimulation as an alternative, off-label, and open-label treatment for various languages disorders. Frequency, intensity, adverse effects, and perception of improvement reported by parents were collected. The main side effects detected were tingling (28.6%) and itching (28.6%), acute mood changes (42.9%), and irritability (35.7%). Transcranial direct current stimulation is a feasible and tolerable technique in children, although studies regarding plastic and cognitive changes in children are needed to confirm its safety. In conclusion, this is a naturalistic report in which we considered transcranial direct current stimulation as feasible in children.
C1 [Andrade, Agnes Carvalho; Magnavita, Guilherme Moreira; Brasil Nunes Allegro, Juleilda Valeria; Saldanha Lucena, Rita de Cassia] Univ Fed Bahia, Med Sch Bahia, Dept Neurosci, Salvador, BA, Brazil.
   [Borges Passos Neto, Carlos Eduardo] Univ Fed Bahia, Med Sch Bahia, Salvador, BA, Brazil.
   [Fregni, Felipe] Harvard Univ, Sch Med, Spaulding Rehabil Hosp, Lab Neuromodulat,Dept Phys Med & Rehabil, Boston, MA USA.
   [Fregni, Felipe] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA.
RP Lucena, RDS (corresponding author), Dept Neurociencias, 32 Av Araujo Pinho, BR-40150110 Salvador, BA, Brazil.
EM rcslucena@yahoo.com.br
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Fregni, Felipe/0000-0001-9359-8643
CR Aman MG, 2005, ARCH GEN PSYCHIAT, V62, P1266
   Benninger DH, 2010, J NEUROL NEUROSUR PS, V81, P1105, DOI 10.1136/jnnp.2009.202556
   Berlim MT, 2013, J PSYCHIATR RES, V47, P1, DOI 10.1016/j.jpsychires.2012.09.025
   Bikson M, 2012, NEUROMODULATION, V15, P306, DOI 10.1111/j.1525-1403.2012.00481.x
   Bleicher EWB, 2009, FOOD DRUG LAW J, V64, P531
   Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002
   Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690
   Brunoni AR, 2012, ESTIMULACAO TRANSCRA, P65
   D'Agati D, 2010, PSYCHIAT RES, V177, P280, DOI 10.1016/j.psychres.2010.03.004
   Enticott PG, 2012, BRAIN STIMUL, V5, P30, DOI 10.1016/j.brs.2011.02.001
   Frye RE, 2008, J CHILD NEUROL, V23, P79, DOI 10.1177/0883073807307972
   Gilbert DL, 2004, CLIN NEUROPHYSIOL, V115, P1730, DOI 10.1016/j.clinph.2003.10.037
   Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9
   Kadosh RC, 2012, CURR BIOL, V22, pR108, DOI 10.1016/j.cub.2012.01.013
   Kirton A, 2008, LANCET NEUROL, V7, P507, DOI 10.1016/S1474-4422(08)70096-6
   Kolb B, 2010, DEV PSYCHOBIOL
   Kolb B, 2012, DEV PSYCHOBIOL, V54, P311, DOI 10.1002/dev.20515
   Kwon HJ, 2011, NEUROSCI LETT, V492, P1, DOI 10.1016/j.neulet.2011.01.007
   Mattai A, 2011, BRAIN STIMUL, V4, P275, DOI 10.1016/j.brs.2011.01.001
   O'Connell NE, 2011, EUR J PHYS REHAB MED, V47, P309
   Rotenberg A, 2009, EPILEPSY BEHAV, V14, P253, DOI 10.1016/j.yebeh.2008.09.007
   Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016
   Shah SS, 2007, ARCH PEDIAT ADOL MED, V161, P282, DOI 10.1001/archpedi.161.3.282
   Shamliyan T, 2012, PEDIATRICS, V129, pE1291, DOI 10.1542/peds.2010-2847
   Sokhadze E, 2010, APPL PSYCHOPHYS BIOF, V35, P147, DOI 10.1007/s10484-009-9121-2
   Stortelder Frans, 2010, J Am Acad Psychoanal Dyn Psychiatry, V38, P503, DOI 10.1521/jaap.2010.38.3.503
   Varga ET, 2011, EPILEPSY RES, V97, P142, DOI 10.1016/j.eplepsyres.2011.07.016
   Walter G, 2001, J CHILD ADOL PSYCHOP, V11, P69, DOI 10.1089/104454601750143483
NR 28
TC 28
Z9 29
U1 0
U2 10
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0883-0738
EI 1708-8283
J9 J CHILD NEUROL
JI J. Child Neurol.
PD OCT
PY 2014
VL 29
IS 10
BP 1360
EP 1365
DI 10.1177/0883073813503710
PG 6
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA AQ5CZ
UT WOS:000342823700024
PM 24049057
DA 2020-12-15
ER

PT J
AU da Silva, LPA
   Nova, CV
   Lucena, R
AF Anjos da Silva, Luzia Poliana
   Nova, Camila Vila
   Lucena, Rita
TI Sickle Cell anemia and hearing loss among children and youngsters:
   literature review
SO BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY
LA English
DT Review
DE anemia; sickle cell; deafness; prognosis; public health
ID AUDITORY FUNCTION
AB Sickle cell anemia is still a significant public health issue in underdeveloped and developing countries. Sickle cell disease is one of the most common inherited diseases in Brazil. It affects mainly the mixed race population. Approximately 1 African-Brazilian child is affected with sickle cell disease for every 37,400 children born alive. Hearing loss has been considered one of the main clinical manifestations, especially in children. However, to date, there are just a hand full of studies in Brazil and the Brazilian state of Bahia has the largest African-descended population, attempting to establish the frequency of this event.
   Objectives: To analyze the major studies associated with the subject, published in the last twenty years in the main indexed databases.
   Methods: To use MEDLINE to identify the main papers published in English in medical literature, between January of 1989 and January of 2009; associating sickle cell anemia and hearing loss, with its clinical outcomes.
   Conclusion: Given that it is always possible to attempt to prevent disabilities, understanding hearing loss in children with sickle cell anemia enables to maximize quality of life and provides for a broader school attendance.
RP da Silva, LPA (corresponding author), Rua Gersino Coelho,Segunda Travessa 09, BR-40255171 Salvador, BA, Brazil.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168
FU CAPESCAPES
FX Study carried out with the support from CAPES. Integral part of the PhD
   thesis "Anemia Falciforme em Criancas e Adolescentes na Bahia: Perfil
   Auditivo, Neurologico e implicacoes clinicas".
CR Alvares Filho Firmino, 1995, Sangre (Saragossa), V40, P97
   AMAYO EO, 1992, E AFR MED J, V69, P660
   ANVISA, 2002, MAN DIAGN TRAT DOENC
   ATSINA KK, 1988, TROP GEOGR MED, V40, P205
   Azevedo C, 2005, ANEMIA FALCIFORME MA, P12
   AZEVEDO ES, 1980, AM J PHYS ANTHROPOL, V53, P509, DOI 10.1002/ajpa.1330530407
   Burch-Sims GP, 2005, J COMMUN DISORD, V38, P321, DOI 10.1016/j.jcomdis.2005.02.007
   Chiodo AA, 1997, J OTOLARYNGOL, V26, P116
   CRAWFORD MR, 1991, EAR HEARING, V12, P349, DOI 10.1097/00003446-199110000-00007
   DIGGS LW, 1956, AM J CLIN PATHOL, V26, P1109
   Downs CR, 2000, J COMMUN DISORD, V33, P111, DOI 10.1016/S0021-9924(99)00027-1
   ELWANY S, 1988, LARYNGOSCOPE, V98, P386
   Embury S, 1994, SICKLE CELL DIS BASI, P599
   Garcia Callejo F J, 2002, Acta Otorrinolaringol Esp, V53, P371
   GTSPN/SMS/SEMUR, 2005, PROGR AT PESS COM DO
   Herrick J.B., 1910, ARCH INTERN MED, V6, P517, DOI 10.1001/archinte.1910.00050330050003
   Juwah AI, 2004, ARCH DIS CHILD, V89, P572, DOI 10.1136/adc.2003.037374
   Koussi A, 2001, Acta Otorhinolaryngol Belg, V55, P235
   Kral MC, 2001, NEUROPSYCHOL REV, V11, P179, DOI 10.1023/A:1012901124088
   Mgbor N, 2004, INT J PEDIATR OTORHI, V68, P1413, DOI 10.1016/j.ijporl.2004.05.009
   MILLER JM, 1988, AM J OTOLARYNG, V9, P302, DOI 10.1016/S0196-0709(88)80038-3
   Ministerio da Saulde, COORD SANG HEM PROGR
   OGAWA K, 1994, ACTA OTO-LARYNGOL, P85
   OGISI FO, 1987, TROP GEOGR MED, V39, P28
   Onakoya P A, 2002, Afr J Med Med Sci, V31, P21
   Ondzotto G, 2002, B SOC PATHOL EXOT, V95, P248
   Piltcher O, 2000, AM J OTOLARYNG, V21, P75, DOI 10.1016/S0196-0709(00)85001-2
   RAMALHO AS, 1986, HEMOGLOBINOPATIAS HE
   Silva José Antonio Novaes da, 2007, Saude soc., V16, P111, DOI 10.1590/S0104-12902007000200011
   Silva Wellington dos Santos, 2006, Cad. Saúde Pública, V22, P2561, DOI 10.1590/S0102-311X2006001200006
   Sims-Burch GP, 2005, J COMMUN DISORD, V38, P321
   ZAGO MA, 1992, TROP GEOGR MED, V44, P317
NR 32
TC 7
Z9 7
U1 0
U2 8
PU ASSOC BRASILEIRA OTORRINOLARINGOLOGIA & CIRURGIA CERVICOFACIAL
PI SAO PAULO
PA AV INDIANOPOLOS 740, MOEMA, SAO PAULO, SP 04062-001, BRAZIL
SN 1808-8694
EI 1808-8686
J9 BRAZ J OTORHINOLAR
JI Braz. J. Otorhinolaryngol.
PD JAN-FEB
PY 2012
VL 78
IS 1
BP 126
EP 131
DI 10.1590/S1808-86942012000100020
PG 6
WC Otorhinolaryngology
SC Otorhinolaryngology
GA 904OW
UT WOS:000301208800020
PM 22392250
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Vieira, C
   Cosmo, C
   Lucena, R
AF Vieira, Camilo
   Cosmo, Camila
   Lucena, Rita
TI The Importance of Methylmalonic Acid Dosage on the Assessment of
   Patients with Neurological Manifestations Following Bariatric Surgery
SO OBESITY SURGERY
LA English
DT Article
ID COBALAMIN DEFICIENCY; GASTRIC BYPASS; VITAMIN-B-12 DEFICIENCY;
   DIAGNOSIS; FOLATE; MALABSORPTION; COMPLICATIONS; CONVULSIONS
AB Vitamin B12 or cyanocobalamin is an important substance that is included in several metabolic pathways. Its deficiency is a common event after bariatric surgery, decreasing the vitamin B12 absorption after almost all of the stomach and duodenum are eliminated from the digestion process. Neurological manifestations of cyanocobalamin deficiency are not uncommon. We report a case of a young woman who developed ataxia, weakness and peripheral neuropathy after bariatric surgery, but with normal value of vitamin B12 dosage. For the diagnosis, it was necessary to dose methylmalonic acid. We discuss the importance of methylmalonic acid dosage after bariatric surgery in patients who present suspect of cyanocobalamin deficiency with normal values of this vitamin and the role of proton pump inhibitor use and vitamin supplementation in patients with early neurological presentation.
C1 [Vieira, Camilo; Cosmo, Camila; Lucena, Rita] Univ Fed Bahia, Clin Neuromuscular Dis, DINEP Neurol & Epidemiol Div, Salvador, BA, Brazil.
RP Vieira, C (corresponding author), Univ Fed Bahia, Clin Neuromuscular Dis, DINEP Neurol & Epidemiol Div, Univ Complex Prof Edgar Santos, Salvador, BA, Brazil.
EM camilovieira@uol.com.br
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168
CR ABARBANEL JM, 1987, NEUROLOGY, V37, P196, DOI 10.1212/WNL.37.2.196
   ALLEN LH, 1995, AM J CLIN NUTR, V62, P1013
   ALLEN RH, 1993, FASEB J, V7, P1344
   Alvarez-Leite JI, 2004, CURR OPIN CLIN NUTR, V7, P569, DOI 10.1097/00075197-200409000-00010
   AMARAL JF, 1985, ANN SURG, V201, P186, DOI 10.1097/00000658-198502000-00009
   Brolin R E, 1998, J Gastrointest Surg, V2, P436, DOI 10.1016/S1091-255X(98)80034-6
   Carmel R, 2000, ANNU REV MED, V51, P357, DOI 10.1146/annurev.med.51.1.357
   Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62
   Dahele A, 2001, AM J GASTROENTEROL, V96, P745, DOI 10.1111/j.1572-0241.2001.03616.x
   deMello CF, 1996, BRAIN RES, V721, P120, DOI 10.1016/0006-8993(96)00117-5
   Diez-Ewald M, 1997, Invest Clin, V38, P191
   Gultepe M, 2003, CLIN BIOCHEM, V36, P275, DOI 10.1016/S0009-9120(03)00033-X
   HALVERSON JD, 1981, ANN SURG, V194, P152, DOI 10.1097/00000658-198108000-00007
   HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001
   Holleland G, 1999, CLIN CHEM, V45, P189
   Juhasz-Pocsine K, 2007, NEUROLOGY, V68, P1843, DOI 10.1212/01.wnl.0000262768.40174.33
   Kumar S, 2004, NEUROL INDIA, V52, P122
   Kvittingen EA, 1997, EUR J PEDIATR, V156, P925, DOI 10.1007/s004310050744
   LINDENBAUM J, 1990, AM J HEMATOL, V34, P99, DOI 10.1002/ajh.2830340205
   Malfatti CRM, 2003, EPILEPSIA, V44, P761, DOI 10.1046/j.1528-1157.2003.42902.x
   MARCUARD SP, 1994, ANN INTERN MED, V120, P211, DOI 10.7326/0003-4819-120-3-199402010-00006
   Morris MS, 2002, J NUTR, V132, P2799
   Norman EJ, 1998, BRIT J HAEMATOL, V100, P614, DOI 10.1046/j.1365-2141.1998.0636k.x
   Parkes E, 2006, AM J MED SCI, V331, P207, DOI 10.1097/00000441-200604000-00007
   Rhode BM, 1996, AM J CLIN NUTR, V63, P103
   Skroubis G, 2002, OBES SURG, V12, P551, DOI 10.1381/096089202762252334
   Snow CF, 1999, ARCH INTERN MED, V159, P1289, DOI 10.1001/archinte.159.12.1289
   STABLER SP, 1990, BLOOD, V76, P871
   Thaisetthawatkul P, 2004, NEUROLOGY, V63, P1462
   Vargas-Ruiz AG, 2008, OBES SURG, V18, P288, DOI 10.1007/s11695-007-9310-0
NR 30
TC 7
Z9 8
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0960-8923
EI 1708-0428
J9 OBES SURG
JI Obes. Surg.
PD DEC
PY 2011
VL 21
IS 12
BP 1971
EP 1974
DI 10.1007/s11695-011-0449-3
PG 4
WC Surgery
SC Surgery
GA 850NM
UT WOS:000297201700024
PM 21688116
DA 2020-12-15
ER

PT J
AU Keck, LS
   Lucena, R
   Schuler, P
   Burton, J
   Desai, B
   Cosio-Lima, L
AF Keck, Lesley S.
   Lucena, Rita
   Schuler, Petra
   Burton, Julia
   Desai, Bhargav
   Cosio-Lima, Ludmila
TI Effect Of Balance And Strength Training On Balance Self-efficacy In
   Older Adults
SO MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the American-College-Sports-Medicine/Inaugural
   World Congress on Exercise is Medicine
CY JUN 05, 2010
CL Baltimore, MD
SP Amer Coll Sports Med
C1 [Keck, Lesley S.; Lucena, Rita; Schuler, Petra; Burton, Julia; Desai, Bhargav; Cosio-Lima, Ludmila] Univ W Florida, Pensacola, FL 32514 USA.
EM lkeck.ce91@gtalumni.org
NR 0
TC 0
Z9 0
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0195-9131
J9 MED SCI SPORT EXER
JI Med. Sci. Sports Exerc.
PD MAY
PY 2010
VL 42
IS 5
SU 1
MA 1825
BP 412
EP 413
DI 10.1249/01.MSS.0000384782.87319.76
PG 2
WC Sport Sciences
SC Sport Sciences
GA 759FO
UT WOS:000290226301480
DA 2020-12-15
ER

PT J
AU Lucena, R
   Cardoso, E
   Melo, A
AF Lucena, Rita
   Cardoso, Eduardo
   Melo, Ailton
TI LEVODOPA RESPONSIVE DYSTONIA SECONDARY TO VIRUS ENCEPHALITIS
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
ID JAPANESE ENCEPHALITIS; MOVEMENT-DISORDERS; PARKINSONISM; PROGNOSIS
C1 [Lucena, Rita; Cardoso, Eduardo; Melo, Ailton] Univ Fed Bahia, DINEP, Div Neurol & Epidemiol, Salvador, BA, Brazil.
RP Melo, A (corresponding author), Av Magalhaes Neto 735-802, BR-41820020 Salvador, BA, Brazil.
EM asm@ufba.br
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR Borghi E, 2005, J MED VIROL, V75, P427, DOI 10.1002/jmv.20285
   FERRAZ HB, 1992, CAN J NEUROL SCI, V19, P504, DOI 10.1017/S0317167100041718
   Gomes I, 1996, ARQ NEURO-PSIQUIAT, V54, P407, DOI 10.1590/S0004-282X1996000300008
   Misra UK, 2002, POSTGRAD MED J, V78, P238, DOI 10.1136/pmj.78.918.238
   Murgod UA, 2001, NEUROLOGY, V57, P2313, DOI 10.1212/WNL.57.12.2313
   PEATFIELD RC, 1987, ACTA NEUROL SCAND, V76, P340, DOI 10.1111/j.1600-0404.1987.tb03591.x
   Pradhan S, 1999, NEUROLOGY, V53, P1781, DOI 10.1212/WNL.53.8.1781
   SCHULTZ DR, 1977, NEUROLOGY, V27, P1095, DOI 10.1212/WNL.27.11.1095
   Segawa M, 2000, BRAIN DEV-JPN, V22, pS65
   Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405
   Ward CD, 2003, MOVEMENT DISORD, V18, P623, DOI 10.1002/mds.10413
   Yokochi M, 2000, BRAIN DEV-JPN, V22, pS81
NR 12
TC 0
Z9 0
U1 0
U2 2
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2009
VL 67
IS 2A
BP 297
EP 298
DI 10.1590/S0004-282X2009000200024
PG 2
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 462FA
UT WOS:000267332500024
PM 19547827
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Lucena, RDG
   de Mello, RJV
   Lessa, JR
   Cavalcante, GM
   Ribeiro, M
AF Lucena, Rita de Cassia G.
   de Mello, Roberto J. V.
   Lessa, Jose Ronaldo, Jr.
   Cavalcante, George M.
   Ribeiro, Marcelo
TI Clinical topographic findings in glioblastoma multiforme and the
   relation with motor impairment
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE glioblastoma multiforme; motor impairment; cerebral topography
ID BRAIN-TUMORS
AB Glioblastoma multiforme (GBM) is the glial tumor with the highest grade of malignity. It mainly affects the cerebral hemispheres, presenting general or focal signs and symptoms, which depend on the size, the location of the lesion and rate of growth of the tumor. Objective: To analyze the relationship between motor impairment and GBM topography. Method: We studied 43 cases of GBM, related to the age, gender, localization and motor impairment. Results: The occurrence of the tumor was preponderant in adults (mean age 55 years old), men (55.82%), and frontal lobe (approximately 40%). The principal motor impairment was herniparesis, with the exception of 2 cases in the frontal lobe, 2 temporal, 1 parietal, 1 occipital and 1 frontotemporal. Conclusion: The clinical-topographic findings lead to consider the infiltrative effects (broad lesions) are responsible for the motor impairment rather than compressive effects (located lesions).
C1 Univ Fed Pernambuco, Dept Patol, Recife, PE, Brazil.
RP Lucena, RDG (corresponding author), Univ Fed Pernambuco, Dept Patol, Recife, PE, Brazil.
EM ricaglu@yahoo.com
CR Atlas SW, 1996, MAGNETIC RESONANCE I, P315
   Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8
   BRANDAO LA, 2002, ESPECTROSCOPIA PROTO, P130
   DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207
   Durmaz R, 1997, CLIN NEUROL NEUROSUR, V99, P117, DOI 10.1016/S0303-8467(97)00014-0
   ESCOBAR A, 2004, REV MEX NEUROCI, V5, P571
   Ferreira NF, 2004, ARQ NEURO-PSIQUIAT, V62, P695, DOI 10.1590/S0004-282X2004000400024
   Grant R, 2004, J NEUROL NEUROSUR PS, V75, P18, DOI 10.1136/jnnp.2004.040360
   KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x
   Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44
   KLEIHUES P, 2000, PATHOLOGY GENETICS T, P29
   LANTOS PL, 2002, GREENFIELDS NEUROPAT, P767
   Law M, 2003, AM J NEURORADIOL, V24, P1989
   Lopez-Gonzalez MA, 2000, SURG NEUROL, V53, P157, DOI 10.1016/S0090-3019(99)00177-9
   MCKINNEY PA, 2004, J NEUROL NEUROSUR S2, V75, pS2
   Mukand JA, 2001, AM J PHYS MED REHAB, V80, P346, DOI 10.1097/00002060-200105000-00005
   Prados MD, 1998, CA-CANCER J CLIN, V48, P331, DOI 10.3322/canjclin.48.6.331
   SANTOS JA, 1999, REV SOC BRASILEIRA C
   Stark AM, 2005, SURG NEUROL, V63, P162, DOI 10.1016/j.surneu.2004.01.028
   Tai YF, 2004, J NEUROL NEUROSUR PS, V75, P669, DOI 10.1136/jnnp.2003.028175
NR 20
TC 1
Z9 1
U1 0
U2 4
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2006
VL 64
IS 2B
BP 441
EP 445
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 068QW
UT WOS:000239390500017
PM 16917616
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Figueiredo, MAA
   Dias, J
   Lucena, R
AF Araujo Figueiredo, Maria Aparecida
   Dias, Juarez
   Lucena, Rita
TI Comments on two cases of botulism in the State of Bahia, Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE botulism; epidemiological surveillance; public health surveillance
AB A report on two cases of botulism, one fatal, in which disease diagnosis was difficult and collaboration between public health and epidemiological surveillance services was poor. The objective of this report is to warn professionals of the seriousness of this disease and to reflect on existing public health surveillance practices.
C1 ESAB, DIVEP, Ctr Atencao Saude Prof Jose Maria Magalhaes Neto, BR-41820000 Salvador, BA, Brazil.
   Secretaria Saude Estado Bahia, BR-41820000 Salvador, BA, Brazil.
   Univ Fed Bahia, Salvador, BA, Brazil.
RP Figueiredo, MAA (corresponding author), ESAB, DIVEP, Ctr Atencao Saude Prof Jose Maria Magalhaes Neto, Av ACM S-N, BR-41820000 Salvador, BA, Brazil.
EM mfigueiredo@saude.ba.gov.br
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168
CR ARAP L, 1993, HIGIENE ALIMENTAR, V7, P32
   FERREIRA MS, 1987, REV I MED TROP, V29, P137, DOI 10.1590/S0036-46651987000300004
   *FUND NAC SAUD, 2002, GUIA VIG EP
   Junqueira V. C. A., 1994, Coletanea do Instituto de Tecnologia de Alimentos, V24, P29
   Moline N, 1996, REV CHIL PEDIATR, V67, P10
   TEIXEIRA CF, 1998, SUS MODELOS ASSISTEN
NR 6
TC 1
Z9 2
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2006
VL 39
IS 3
BP 289
EP 291
DI 10.1590/S0037-86822006000300014
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 068HW
UT WOS:000239365200014
PM 16906257
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Cardoso, ES
   Rodrigues, BM
   Barroso, M
   Menezes, CJ
   Lucena, RS
   Nora, DB
   Melo, A
AF Cardoso, ES
   Rodrigues, BM
   Barroso, M
   Menezes, CJ
   Lucena, RS
   Nora, DB
   Melo, A
TI Botulinum toxin type A for the treatment of the spastic equinus foot in
   cerebral palsy
SO PEDIATRIC NEUROLOGY
LA English
DT Article
ID PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; MANAGEMENT; MUSCLE
AB Muscle overactivity, one of the cardinal features of spasticity, is a common sequel of cerebral palsy. In this group of patients spasticity is responsible for several limitations that interfere with gait, causing variable functional disability. Drugs such as baclofen, tizanidine, or benzodiazepines, or even definitive treatments such as orthopedics or neurosurgeries are generally prescribed with uncertain results. The use of botulinum toxin type A has been frequently suggested for the treatment of spastic equinus foot in cerebral palsy, but few studies with adequate methodology support this idea. The present paper reviews and summarizes the data of published double-blind, randomized clinical trials to assess, with a meta-analysis, if botulinum toxin type A is an adequate treatment for spasticity caused by cerebral palsy. The results reveal a statistical superiority of botulinum toxin type A over placebo on gait improvement, tested using the Physician Rating Scale and Video Gait Analysis (Peto odds ratio = 3.99, 95% confidence interval = 2.20-7.22) in patients with spastic equinus foot. The botulinum toxin group also presented better results in the subjective assessment than the placebo group (Peto odds ratio = 3.49, 95% confidence interval = 1.50-8.12). Adverse events were more frequently observed after the use of botulinum toxin type A, but they were considered mild and self-limited. (c) 2006 by Elsevier Inc. All rights reserved.
C1 Univ Fed Bahia, Neurol & Epidemiol Div, Salvador, BA, Brazil.
RP Melo, A (corresponding author), Av Magalhaes Neto 735 Ap 802, BR-41820001 Salvador, BA, Brazil.
EM asm@ufba.br
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR Baker R, 2002, DEV MED CHILD NEUROL, V44, P666, DOI 10.1111/j.1469-8749.2002.tb00268.x
   Bakheit AMO, 2004, J NEUROL NEUROSUR PS, V75, P665, DOI 10.1136/jnnp.2003.026096
   Cardoso E, 2005, ARQ NEURO-PSIQUIAT, V63, P30, DOI 10.1590/S0004-282X2005000100006
   Graham HK, 2000, GAIT POSTURE, V11, P67, DOI 10.1016/S0966-6362(99)00054-5
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   KIM IW, 2002, AM J PHYS REHABIL, V81, P297
   KOMAN LA, 1994, J PEDIATR ORTHOPED, V14, P299, DOI 10.1097/01241398-199405000-00005
   Koman LA, 2004, LANCET, V363, P1619, DOI 10.1016/S0140-6736(04)16207-7
   Koman LA, 2000, J PEDIATR ORTHOPED, V20, P108, DOI 10.1097/00004694-200001000-00022
   Love SC, 2001, EUR J NEUROL, V8, P50, DOI 10.1046/j.1468-1331.2001.00038.x
   MELO A, 2005, ABPC, V1, P18
   Olney SJ, 1995, PHYSICAL THERAPY CHI, P489
   Pidcock FS, 2004, J PEDIATR-US, V145, pS33, DOI 10.1016/j.jpeds.2004.05.020
   SIMPSON DM, 1997, MUSCLE NERVE       S, V6, P169
   Sutherland DH, 1999, GAIT POSTURE, V10, P1, DOI 10.1016/S0966-6362(99)00012-0
   Ubhi T, 2000, ARCH DIS CHILD, V83, P481, DOI 10.1136/adc.83.6.481
NR 16
TC 35
Z9 34
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD FEB
PY 2006
VL 34
IS 2
BP 106
EP 109
DI 10.1016/j.pediatrneurol.2005.08.010
PG 4
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 013NW
UT WOS:000235417000004
PM 16458821
DA 2020-12-15
ER

PT J
AU Marques, W
   Freitas, MR
   Nascimento, OJM
   Oliveira, AB
   Calia, L
   Melo, A
   Lucena, R
   Rocha, V
   Barreira, AA
AF Marques, W
   Freitas, MR
   Nascimento, OJM
   Oliveira, AB
   Calia, L
   Melo, A
   Lucena, R
   Rocha, V
   Barreira, AA
TI 17p duplicated Charcot-Marie-Tooth 1A - Characteristics of a new
   population
SO JOURNAL OF NEUROLOGY
LA English
DT Article
DE Charcot-Marie-Tooth 1A; demyelinating neuropathy; hereditary motor and
   sensory neuropathy; nerve conduction studies; 17p11-2-p12 duplication
ID DISEASE TYPE 1A; NEUROPATHY TYPE-I; MOTOR SENSORY NEUROPATHY; HEREDITARY
   MOTOR; 17P11.2 DUPLICATION; PRESSURE PALSIES; NERVE-CONDUCTION;
   RECOMBINATION HOTSPOT; MOLECULAR DIAGNOSIS; HOT-SPOT
AB The most frequent type of Charcot-Marie-Tooth (CMT) neuropathy is that associated with the 17p11.2-p12 chromosome duplication, whose characteristics have been well described in European and North American populations. In this study, we analyzed a Brazilian population exhibiting the mutation, found in 57 patients from 42 families (79%) of a cohort of 53 families with demyelinating CMT. Almost 20% of the duplicated cases were sporadic. In 77% of the duplicated families the mutation event occurred in the hot spot area of the CMT1A-Rep region. Forty-five percent of patients were females, 84% were Caucasians and 13% of African descent. Distal limb weakness was the most frequent abnormality, appearing in 84% of patients, although uncommon manifestations such as severe proximal weakness, floppy baby syndrome, diaphragmatic weakness and severe scoliosis were also observed. One patient was wheelchair-bound, and three suffered severe hand weakness. Sensory abnormalities were detected in 84% of the cases, but 80% were unaware of this impairment. Twelve patients complained of positive sensory manifestations such as pain and paresthesias. Progression was reported by 40%. Motor conduction velocities in the upper limbs were always less than 35 m/s, and less than 30.4 m/s in the peroneal nerve. The findings of this study expand the clinical spectrum of the disease.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Neurol, BR-14048900 Sao Paulo, Brazil.
   Univ Fed Fluminense, Sch Med, Dept Neurol, BR-24220100 Rio De Janeiro, Brazil.
   Univ Fed Sao Paulo, Sch Med, Dept Neurol, BR-0403931 Sao Paulo, Brazil.
   Univ Fed Bahia, Sch Med, Fac Med, Dept Neurol, Salvador, BA, Brazil.
RP Marques, W (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Neurol, Av Bandeirantes 3900, BR-14048900 Sao Paulo, Brazil.
EM wmjunior@fmrp.usp.br
RI Barreira, Amilton/A-1159-2008; Lucena, Rita/L-9842-2013; Marques,
   Wilson/G-4240-2012
OI Lucena, Rita/0000-0002-6190-9168; Marques, Wilson/0000-0002-4589-2749;
   Melo, Ailton/0000-0001-7457-0573; Barreira, Amilton/0000-0002-4791-223X
CR AIYESIMOJU AB, 1984, NEUROLOGY, V34, P361, DOI 10.1212/WNL.34.3.361
   Auer-Grumbach M, 2000, MUSCLE NERVE, V23, P1243, DOI 10.1002/1097-4598(200008)23:8<1243::AID-MUS13>3.0.CO;2-Z
   BAKER RS, 1979, NEUROPADIATRIE, V10, P290, DOI 10.1055/s-0028-1085331
   BELLONE E, 1992, J MED GENET, V29, P492
   Birouk N, 1997, BRAIN, V120, P813, DOI 10.1093/brain/120.5.813
   Boerkoel CF, 2002, ANN NEUROL, V51, P190, DOI 10.1002/ana.10089
   BRICE A, 1992, J MED GENET, V29, P807, DOI 10.1136/jmg.29.11.807
   BUCHTHAL F, 1977, BRAIN, V100, P41, DOI 10.1093/brain/100.1.41
   Butefisch C, 1999, NEUROLOGY, V52, P890, DOI 10.1212/WNL.52.4.890
   Butefisch CM, 1998, MUSCLE NERVE, V21, P788
   CARDOSO FEC, 1993, MUSCLE NERVE, V16, P904, DOI 10.1002/mus.880160904
   Carter GT, 1998, ARCH PHYS MED REHAB, V79, P1560, DOI 10.1016/S0003-9993(98)90421-X
   Carvalho-Silva DR, 2001, AM J HUM GENET, V68, P281, DOI 10.1086/316931
   CHANDA S, 1992, COMP PHYSIOL ECOL, V17, P1
   de Jonghe P, 1999, ANN NY ACAD SCI, V883, P389
   DEVISSER M, 1990, MUSCLE NERVE, V13, P40, DOI 10.1002/mus.880130109
   Dubourg O, 2001, NEUROMUSCULAR DISORD, V11, P458, DOI 10.1016/S0960-8966(00)00222-4
   DYCK PJ, 1993, PERIPHERAL NEUROPATH, V2, P1095
   FREITAS MRG, 1990, ARQ NEURO-PSIQUIAT, V26, P165
   Gabreels-Festen A, 1999, J NEUROL NEUROSUR PS, V66, P569, DOI 10.1136/jnnp.66.5.569
   Garcia A, 1998, NEUROLOGY, V50, P1061, DOI 10.1212/WNL.50.4.1061
   HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259
   HOOGENDIJK JE, 1994, MUSCLE NERVE, V17, P85, DOI 10.1002/mus.880170112
   HOOGENDIJK JE, 1991, HDB CLIN NEUROLOGY, P185
   IONASESCU VV, 1995, MUSCLE NERVE, V18, P267, DOI 10.1002/mus.880180302
   IONASESCU VV, 1993, MUSCLE NERVE, V16, P1232, DOI 10.1002/mus.880161114
   JONES HR, 1990, MUSCLE NERVE, V13, P338, DOI 10.1002/mus.880130410
   KAKU DA, 1993, NEUROLOGY, V43, P2664, DOI 10.1212/WNL.43.12.2664
   KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806
   Kessali M, 1997, NEUROLOGY, V48, P867, DOI 10.1212/WNL.48.4.867
   Krajewski KM, 2000, BRAIN, V123, P1516, DOI 10.1093/brain/123.7.1516
   Lewis RA, 2000, MUSCLE NERVE, V23, P1472, DOI 10.1002/1097-4598(200010)23:10<1472::AID-MUS3>3.0.CO;2-#
   Lopes J, 1996, AM J HUM GENET, V58, P1223
   LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4
   MACMILLAN JC, 1992, J MED GENET, V29, P12, DOI 10.1136/jmg.29.1.12
   Marques Junior W, 1992, Arq Neuropsiquiatr, V50, P433
   Marques W, 1998, ANN NEUROL, V43, P680, DOI 10.1002/ana.410430521
   MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176
   Murakami T, 1999, MUSCLE NERVE, V22, P1593, DOI 10.1002/(SICI)1097-4598(199911)22:11<1593::AID-MUS17>3.0.CO;2-H
   Nelis E, 1996, EUR J HUM GENET, V4, P25
   PATEL P, 1992, J INT BUS STUD, V22, P1
   Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W
   Reilly MM, 1998, J NEUROL, V245, P6
   Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288
   ROSEN SA, 1989, NEUROLOGY, V39, P1173, DOI 10.1212/WNL.39.9.1173
   SKRE H, 1974, CLIN GENET, V6, P98
   SNIPES GJ, 1995, J ANAT, V186, P483
   Stronach EA, 1999, J PERIPHER NERV SYST, V4, P117
   Thomas PK, 1997, BRAIN, V120, P465, DOI 10.1093/brain/120.3.465
   Timmerman V, 1997, J MED GENET, V34, P43, DOI 10.1136/jmg.34.1.43
   TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171
   UNCINI A, 1994, ANN NEUROL, V35, P552, DOI 10.1002/ana.410350508
   VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166
   WEBB LB, 1998, MUSCLE NERVE, V21, P1575
   WISE CA, 1993, AM J HUM GENET, V53, P853
NR 55
TC 34
Z9 34
U1 0
U2 2
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD AUG
PY 2005
VL 252
IS 8
BP 972
EP 979
DI 10.1007/s00415-005-0797-9
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA 956NU
UT WOS:000231307700017
PM 15765265
DA 2020-12-15
ER

PT J
AU Cardoso, E
   Rodrigues, B
   Lucena, R
   de Oliveira, IR
   Pedreira, G
   Melo, A
AF Cardoso, E
   Rodrigues, B
   Lucena, R
   de Oliveira, IR
   Pedreira, G
   Melo, A
TI Botulinum toxin type A for the treatment of the upper limb spasticity
   after stroke - A meta-analysis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE stroke; spasticity; botulinum toxin; rehabilitation
ID DOUBLE-BLIND; MUSCLE SPASTICITY; PLACEBO; EFFICACY; SAFETY
AB Muscle over-activity is one of the cardinal features of spasticity and it is a common disability of stroke patients. In this group, spasticity is responsible for several limitations that interfere in their daily activities and quality of life. To treat spasticity, neurologists usually prescribe drugs as baclofen, tizanidine or benzodiazepines or even use definitive treatment as phenol or surgery. Authors suggest the use of botulinum toxin type A (BTX-A) for spasticity in the upper limbs after stroke, but there are few papers with adequate methodology supporting this idea. In this article we summarize the data of previous double-blind, randomised clinical trials to asses, with a meta-analysis, if BTX-A is an adequate treatment for spasticity due to stroke. The results show a statistical superiority of BTX-A ov%r placebo on reducing muscle tone by the Modified Ashworth Scale (WMD = 0.95 [0.74 to 1.17]) in patients with post-stroke upper limb spasticity.
C1 Univ Fed Bahia, DINEP, Div Neurol, Salvador, BA, Brazil.
RP Cardoso, E (corresponding author), Avenida Magalhaes Neto 735-802, BR-41820020 Salvador, BA, Brazil.
RI de Oliveira, Irismar R/B-4172-2009; Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR Bakheit AMO, 2000, STROKE, V31, P2402, DOI 10.1161/01.STR.31.10.2402
   Bakheit AMO, 2004, J NEUROL NEUROSUR PS, V75, P665, DOI 10.1136/jnnp.2003.026096
   Bakheit AMO, 2001, EUR J NEUROL, V8, P559, DOI 10.1046/j.1468-1331.2001.00277.x
   Bhakca B, 2001, J NEUROL NEUROSUR PS, V70, P821
   BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0
   BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206
   Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   MIZRAHI EM, 1979, ANN NEUROL, V5, P494
   NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9
   Rousseaux M, 2002, J NEUROL, V249, P76, DOI 10.1007/PL00007851
   Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306
   Smith SJ, 2000, CLIN REHABIL, V14, P5, DOI 10.1191/026921500666642221
   WADE DT, 1992, BRIT MED J, V304, P609, DOI 10.1136/bmj.304.6827.609
NR 14
TC 39
Z9 43
U1 0
U2 4
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2005
VL 63
IS 1
BP 30
EP 33
DI 10.1590/S0004-282X2005000100006
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 912TV
UT WOS:000228103700006
PM 15830061
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Lucena, R
   Fonseca, N
   Nunes, L
   Cardoso, A
   Goes, J
   Correia, MC
   Cardoso, E
   Queiros, F
   Anjos, LP
   Vila-Nova, C
   Melo, A
AF Lucena, R
   Fonseca, N
   Nunes, L
   Cardoso, A
   Goes, J
   Correia, MC
   Cardoso, E
   Queiros, F
   Anjos, LP
   Vila-Nova, C
   Melo, A
TI Intra-hospital lethality among infants with pyogenic meningitis
SO PEDIATRIC NEUROLOGY
LA English
DT Article
ID ACUTE BACTERIAL-MENINGITIS; CHILDREN; INFECTIONS
AB Predictor variables of intra-hospital lethality among infants with pyogenic meningitis due to Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae were identified using data from a follow-up study of infants with bacterial meningitis. The infants who were admitted to Couto Maia Hospital from March 1, 1997 to December 31, 1997 presenting with symptoms of bacterial meningitis were identified and included in a database. An analysis of the clinical and laboratory information was performed using EPI info 6.01b and SPSS 6.1 statistical programs. The total mortality rate was 17.1%, and the majority of deaths occurred within 48 hours of hospitalization. Factors associated most frequently with poor outcome included absence of respiratory infection, high cerebrospinal fluid protein, and compromised cranial nerves. Early identification of major risk groups is important to adopt measures to improve prognosis. (c) 2005 by Elsevier Inc. All rights reserved.
C1 Univ Fed Bahia, DINEP, Salvador, BA, Brazil.
RP Lucena, R (corresponding author), Hosp Clin, Div Neurol & Epidemiol, BR-40110170 Salvador, BA, Brazil.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR Ahman H, 1998, PEDIATR INFECT DIS J, V17, P211, DOI 10.1097/00006454-199803000-00008
   AKPEDE GO, 1994, J TROP PEDIATRICS, V40, P231, DOI 10.1093/tropej/40.4.231
   ASHWAL S, 1990, J PEDIATR-US, V117, P523, DOI 10.1016/S0022-3476(05)80683-3
   Barzilai A, 1999, PEDIATR INFECT DIS J, V18, P301, DOI 10.1097/00006454-199903000-00022
   BUCHANAN GA, 1994, SOUTHERN MED J, V87, P38, DOI 10.1097/00007611-199401000-00009
   Casado Flores J, 1997, An Esp Pediatr, V47, P466
   Chang CJ, 2004, BRAIN DEV-JPN, V26, P168, DOI 10.1016/S0387-7604(03)00122-0
   Chang CJ, 2003, PEDIATR NEUROL, V29, P288, DOI 10.1016/S0887-8994(03)00273-X
   Chang YC, 1998, PEDIATR NEUROL, V18, P213, DOI 10.1016/S0887-8994(97)00184-7
   COMMEY JOO, 1994, E AFR MED J, V71, P113
   El Bashir H, 2003, ARCH DIS CHILD, V88, P615, DOI 10.1136/adc.88.7.615
   FAJARDO JE, 1989, PEDIATR NEUROL, V5, P37, DOI 10.1016/0887-8994(89)90007-6
   Gomes I, 1996, ARQ NEURO-PSIQUIAT, V54, P407, DOI 10.1590/S0004-282X1996000300008
   Hall CB, 1996, PEDIATRICS, V97, P404
   LAINE J, 1991, ACTA PAEDIATR SCAND, V80, P1031
   Lucena R, 2002, ARQ NEURO-PSIQUIAT, V60, P281, DOI 10.1590/S0004-282X2002000200018
   Molyneux E, 1998, TROP MED INT HEALTH, V3, P610, DOI 10.1046/j.1365-3156.1998.00278.x
   NAN R, 2004, NEUROLOGY, V62, P509
   Peltola H, 1998, PEDIATR INFECT DIS J, V17, pS148, DOI 10.1097/00006454-199809001-00011
   SALIH MAM, 1990, ANN TROP PAEDIATR, V10, P203, DOI 10.1080/02724936.1990.11747431
   Scheifele DW, 1996, CAN MED ASSOC J, V154, P1041
   Taraszkiewicz F, 1996, Pediatr Pol, V71, P689
   URWIN G, 1994, BRIT MED J, V309, P1412, DOI 10.1136/bmj.309.6966.1412
   Zimmer SM, 2004, EXPERT OPIN PHARMACO, V5, P855, DOI 10.1517/14656566.5.4.855
NR 24
TC 2
Z9 4
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD MAR
PY 2005
VL 32
IS 3
BP 180
EP 183
DI 10.1016/j.pediatrneurol.2004.09.016
PG 4
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA 914BD
UT WOS:000228198600006
PM 15730898
DA 2020-12-15
ER

PT J
AU Mota, M
   Melo, A
   Burak, C
   Daltro, C
   Rodrigues, B
   Lucena, R
AF Mota, M
   Melo, A
   Burak, C
   Daltro, C
   Rodrigues, B
   Lucena, R
TI Anthropometric cranial measures of normal newborn
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Spanish
DT Article
DE cephalic perimeter; biauricular distance; cephalic index; newborns;
   anthropometric measures; fontanel
AB Objective: The study has been carried out through anthropometric measures of Bahian newborns, to define measures according with the reality of this region. Method: Study type transversal cut in term babies with the measures of cephalic perimeter, biauricular and anteroposterior distances, fontanel and cephalic index. Results: 388 babies, 204 (52.6%) of males and 184 (47.4%) females had been evaluated. The cephalic perimeter varied between 31.0 and 38.0 cm, with 34.4 +/- 1.2 average. The cephalic index varied between 0.75 and 1.06, with 0.91 +/- 0.05 average. Conclusion: The anthropometric measures are surveyed aiming at precocious detention of anomalies. Possibly, these measures can be influenced by racial factors; however, the measures carried through in Brazil follow values of foreign authors. Thus, the study shows data of a Northeastern region and points out the importance of the accomplishment of multicentric studies.
C1 Univ Fed Bahia, Salvador, BA, Brazil.
   HCSR, Serv Neonatol, Salvador, BA, Brazil.
RP Mota, M (corresponding author), Rua Antonio Silva Coelho 16, BR-41750040 Salvador, BA, Brazil.
EM clinicaanemm@hotmail.com
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6
   BUCY PC, 1966, PRACTIQUE PEDIAT, P17
   DIAMENT AJ, 1985, MONOGRAFIAS MED, V24, P24
   DIAMENT AJ, 1976, EVOLUCAO NEUROLOGICA
   GESELL A, 1938, PSICHOLOGY GROWTH IN
   GOMES U A, 1989, Arquivos de Neuro-Psiquiatria, V47, P392
   LEFEVRE A. B., 1971, PROPEDEUTICA NEUROLO, P413
   LEFEVRE AFB, 1950, THESIS U SAO PAULO S
   MARCONDES E, 1976, ARQ NEURO-PSIQUIAT, V34, P325
   MARCONDES E, 1971, ANAIS NESTLE, V84, P10
   *MIN SAUD, 1986, PROGR ASS INT SAUD C
   MORENORUIZ ME, 2000, B MED HOSP INFANT M, V59, P599
   Nelson W.E., 1964, TXB PEDIAT
   Norusis M. J., 1998, STAT PACKAGE SOCIAL
   PRECHTI HFR, 1977, CIN DEV MED, V63
   PRECHTI HFR, 1960, LONG TERM VALUE NEUR
   Watson EH, 1962, GROWTH DEV CHILDREN
NR 17
TC 6
Z9 10
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2004
VL 62
IS 3A
BP 626
EP 629
DI 10.1590/S0004-282X2004000400011
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 853AV
UT WOS:000223799400011
PM 15334220
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Anjos, LP
   Queiros, F
   Pereira, MC
   Brandao, M
   Melo, A
   Lucena, R
AF Anjos, LP
   Queiros, F
   Pereira, MC
   Brandao, M
   Melo, A
   Lucena, R
TI Audiologic late prognosis due to meningitis in children
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Spanish
DT Article
DE meningitis; children; prognosis; hearing loss; neurological impairment;
   communication
ID BACTERIAL-MENINGITIS; ETIOLOGY; INFANTS
AB Introduction: Auditory deficit has been considered one of the main late manifestations of meningitis, when it occurs during the two first years of life. Few studies have been conducted in Brazil explaining the evolution of children who had meningitis and the percentage, as well the neurological gravity, the auditory problems and sequels after the children left the hospital. Objective:To characterize the main auditory and neurological correlation, delineating the profile of the auditory deficits found five years after the central nervous system infection. Method: We evaluated children between 5 and 7 years old, admitted in Couto Maia Hospital in the year of 1997, that had been diagnosed with meningitis at an age of two years or below. Results: 19 children passed through the neurological and auditory evaluation. The average age was 6 years and 68.42% were male. In relation to etiology, 52.63% pyogenic, 42.1% viral, 5.26% due to tuberculosis. Auditory alterations had occurred in 26.31% of this population. Conclusion: Auditory problems cause academic and social implications in the affected children, especially those of school age. We confirmed the necessity of audiologic following of all children with previous history of meningitis.
C1 Univ Estado Bahia, Dept Ciencias Vida, Salvador, BA, Brazil.
   Univ Estado Bahia, Div Neurol, Neurol Serv, Salvador, BA, Brazil.
   CNPq, Rio De Janeiro, Brazil.
RP Anjos, LP (corresponding author), Rua Gersino Coelhol 2A Traversa 09, BR-40255170 Salvador, BA, Brazil.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR Alberti P W, 1993, World Health Forum, V14, P1
   Azevedo MF, 1991, TEMAS DESENVOLVIMENT, V3, P11
   BORGES SC, 1998, FUNDAMENTOS FONOAUDI, P107
   BRYAN JP, 1990, REV INFECT DIS, V12, P128
   Couto MIV, 1999, ARQ NEURO-PSIQUIAT, V57, P808, DOI 10.1590/S0004-282X1999000500012
   Eckel HE, 1998, HNO, V46, P252, DOI 10.1007/s001060050234
   ELIAS K, 1994, PROFONO REV ATUALIZA, V1, P3
   FORTA S, 1998, FUNDAMENTOS FONOAUDI, P41
   GOES J, 2003, THESIS MESTRADO U FE
   Gomes I, 1996, ARQ NEURO-PSIQUIAT, V54, P407, DOI 10.1590/S0004-282X1996000300008
   GUARDIOLA A, 1994, THESIS U FEDERAL RIO
   Kesser BW, 1999, OTOLARYNG HEAD NECK, V120, P628, DOI 10.1053/hn.1999.v120.a92772
   LALWANI AK, 1998, PEDIAT OTOLOGY NEURO
   LEFEVRE AB, 1975, DISFUNCAO CEREBRAL M, P234
   Lucena R, 2002, ARQ NEURO-PSIQUIAT, V60, P281, DOI 10.1590/S0004-282X2002000200018
   Lucena R, 1996, ARQ NEURO-PSIQUIAT, V54, P571, DOI 10.1590/S0004-282X1996000400004
   Northern JL, 1991, HEARING CHILDREN
   OLIVEIRA P, 2002, REV BRAS OTORINOLARI, V68, P18
   OZUMBA UC, 1995, CTR AFR J MED, V41, P93
   SIBBALDI A, 1997, MANUAL OTORRINOLARIN, P291
   Zakzouk SM, 1997, J OTOLARYNGOL, V26, P335
NR 21
TC 4
Z9 5
U1 0
U2 0
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2004
VL 62
IS 3A
BP 635
EP 640
DI 10.1590/S0004-282X2004000400013
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 853AV
UT WOS:000223799400013
PM 15334222
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Queiros, F
   Duarte, G
   Correia, C
   Sergio, JG
   Vila-Nova, C
   Lucena, R
AF Queiros, F
   Duarte, G
   Correia, C
   Sergio, JG
   Vila-Nova, C
   Lucena, R
TI Worster-Drought syndrome: case report and distinction in relation to
   Foix-Chavany-Marie syndrome
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE Worster-Drought syndrome; speech pathology; Foix-Chavany-Marie syndrome;
   abortives; oral motricity; cognitive alterations
AB Worster-Drought syndrome is a clinical entity resulting from cortico-nuclear tract or cerebral cortex injury, without defined etiology, characterized by alteration of the muscles that control the lips, jaw, tongue, soft palate and pharynx. The main clinical manifestations are alterations in the fonation and deglutition. We describe the case of a 15 year old female patient, displaying the cited syndrome. The clinical, radiological and neurophysiological findings are compared with the described data in the literature. We question the connection between Worster-Drought and Foix-Chavany-Marie syndroms, as well as the possible relationship with use of abortive drugs and similar oromotor problems as found in these two syndromes.
C1 Univ Fed Bahia, Fonoaudiol Clin, Mestranda Neurociencias, Salvador, BA, Brazil.
   Univ Fed Bahia, Med Acad, Salvador, BA, Brazil.
   Hosp Sao Rafael, Med Neurofisiol, Salvador, BA, Brazil.
RP Queiros, F (corresponding author), Rua Boa Fe 72E, BR-41185290 Salvador, BA, Brazil.
EM nandafono@terra.com.br
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168
CR Ann M Y, 2001, Zhonghua Yi Xue Za Zhi (Taipei), V64, P540
   CALWSON A, 1992, BENDER INFANTIL MANU
   Christen HJ, 2000, DEV MED CHILD NEUROL, V42, P122, DOI 10.1017/S0012162200000232
   Clark M, 2000, BRAIN, V123, P2160, DOI 10.1093/brain/123.10.2160
   LIPSON AH, 1991, TERATOLOGY, V43, P557, DOI 10.1002/tera.1420430608
   MURDOCH BE, 1997, DESENVOLVIMENTO FALA
   Nevo Y, 2001, PEDIATR NEUROL, V24, P153, DOI 10.1016/S0887-8994(00)00245-9
   ORTIZ KZ, 1997, TRATADO FONOAUDIOLOG, P939
   REED H, 1953, BR BONE JOINT SURG, V35, P437
   WEISS MLL, 2002, PSICOPEDAGOGIA CLIN
   WELLER M, 1993, J NEUROL, V240, P199, DOI 10.1007/BF00818705
   WORSTERDROUGHT C, 1974, DEV MED CHILD NEUROL, V16, P1
   Zorzi J. L., 1998, FUNDAMENTOS FONOAUDI, P59
NR 13
TC 2
Z9 2
U1 0
U2 4
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2004
VL 62
IS 3B
BP 906
EP 910
DI 10.1590/S0004-282X2004000500035
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 907EH
UT WOS:000227697700035
PM 15476096
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Lucena, R
   Gomes, I
   Cardoso, E
   Goes, J
   Nunes, L
   Cardoso, A
   Rodrigues, B
   Souza, M
   Novaes, MA
   Melo, A
AF Lucena, R
   Gomes, I
   Cardoso, E
   Goes, J
   Nunes, L
   Cardoso, A
   Rodrigues, B
   Souza, M
   Novaes, MA
   Melo, A
TI Clinical and laboratorial aspects of acute bacterial meningitis in
   infants
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE acute bacterial meningitis; infants; laboratorial; clinical
ID B MENINGITIS; CHILDREN; EPIDEMIOLOGY; VACCINE
AB Objective: to describe clinical and laboratorial characteristics of acute bacterial meningitis in infants. Method: data from the prospective follow-up of infants with acute bacterial meningitis, admitted at the Hospital Couto Maia between March and December 1997, were analyzed with specific statistical software. Results: acute bacterial meningitis was more prevalent in infants with ages varying from 6 months to 1 year. The most frequent etiologic agent was Haemophilus influenzae. The global lethality was 25.9% and among the survivors 39.3% left the hospital with some abnormality in the neurological exam compatible with the brain involvement. Conclusion: acute bacterial meningitis in infants is a high lethality disease that in the majority of cases can be prevented. We consider of great relevance the adoption of health prevention strategies in order to reduce the incidence of this disease.
C1 Univ Fed Bahia, Div Neurol Epidemiol, Salvador, BA, Brazil.
   Bolsistas CNPq, Brasilia, DF, Brazil.
   Bolsista CAPES, Bolsista, Brazil.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR Akpede G O, 1995, West Afr J Med, V14, P217
   AKPEDE GO, 1994, ANN TROP PAEDIATR, V14, P245, DOI 10.1080/02724936.1994.11747724
   Bhat B V, 1991, J Indian Med Assoc, V89, P224
   Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499
   Dagan R, 1999, VACCINE, V17, P134, DOI 10.1016/S0264-410X(98)00165-0
   Gomes I, 1996, ARQ NEURO-PSIQUIAT, V54, P407, DOI 10.1590/S0004-282X1996000300008
   Hussey G, 1997, S AFR MED J, V87, P51
   Lucena R, 1996, ARQ NEURO-PSIQUIAT, V54, P571, DOI 10.1590/S0004-282X1996000400004
   Moyen G, 1999, ARCH PEDIATRIE, V6, P108, DOI 10.1016/S0929-693X(99)80088-8
   MULHOLLAND EK, 1994, LANCET, V343, P794, DOI 10.1016/S0140-6736(94)91870-8
   Novakova E, 1999, EUR J CLIN MICROBIOL, V18, P409, DOI 10.1007/s100960050309
   Peltola H, 1999, INFECT DIS CLIN N AM, V13, P685, DOI 10.1016/S0891-5520(05)70101-X
   URWIN G, 1994, BRIT MED J, V309, P1412, DOI 10.1136/bmj.309.6966.1412
NR 13
TC 6
Z9 8
U1 0
U2 0
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD JUN
PY 2002
VL 60
IS 2A
BP 281
EP 284
DI 10.1590/S0004-282X2002000200018
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 557CV
UT WOS:000175890500019
PM 12068360
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Lucena, R
AF Lucena, R
TI Clinical and laboratorial aspects of aseptic meningitis associated with
   MMR (measles-mumps-rubella) vaccine at a referral hospital in the State
   of Bahia (abstract). Thesis. Salvador, 2001.
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE aseptic meningitis; MMR vaccine; mumps; measles; rubella
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 2002
VL 60
IS 1
BP 176
EP 177
DI 10.1590/S0004-282X2002000100037
PG 2
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 535ZZ
UT WOS:000174677400037
OA DOAJ Gold
DA 2020-12-15
ER

PT J
AU Gomes, I
   Veiga, M
   Correa, D
   Meza-Lucas, A
   Mata, O
   Garcia, RC
   Osornio, A
   Rabelo, R
   Lucena, R
   Melo, A
AF Gomes, I
   Veiga, M
   Correa, D
   Meza-Lucas, A
   Mata, O
   Garcia, RC
   Osornio, A
   Rabelo, R
   Lucena, R
   Melo, A
TI Cysticercosis in epileptic patients of Mulungu do Morro Northeastern
   Brazil
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE cysticercosis; epilepsy; seizures; neurocysticercosis; epidemiology
ID TAENIA-SOLIUM; NEUROCYSTICERCOSIS; MEXICO; COMMUNITY; ANTIGENS; GRANDE;
   STATE
AB With the aim to study the magnitude of infection by the metacestode of Tuenia solium in a population of epileptic patients in the arid region of Bahia, Northeastern Brazil, we examined 200 consecutive cases who attended an ambulatory clinic in the district of Mulungu do Morro. Sixty-six of the patients had a diagnosis of epilepsy. From them 10 (15.2%) presented antibodies against a specific fraction of antigens in Western blot, and 4 (6.0%) had circulating parasite products, as tested by capture ELISA. Only 1 case was positive for antibodies and antigens. We found that the frequency of seropositivity was related to the time without epileptic seizure. We conclude that cysticercosis si endemic in the region of Mulungu do Morro and that it is related to a benign form of epilepsy.
C1 Univ Fed Bahia, BR-41170290 Salvador, BA, Brazil.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR Agapejev Svetlana, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P207, DOI 10.1590/S0036-46651996000300008
   ArandaAlvarez JG, 1995, ANN TROP MED PARASIT, V89, P689, DOI 10.1080/00034983.1995.11813004
   ARRUDA W O, 1991, Arquivos de Neuro-Psiquiatria, V49, P251
   DAVIS LE, 1991, EUR NEUROL, V31, P229, DOI 10.1159/000116683
   DEALBUQUERQUE ES, 1995, ARQ NEURO-PSIQUIAT, V53, P464, DOI 10.1590/S0004-282X1995000300016
   GARCIA HH, 1991, LANCET, V338, P549
   Garcia HH, 1997, T ROY SOC TROP MED H, V91, P176, DOI 10.1016/S0035-9203(97)90213-3
   GoncalvesCoelho TD, 1996, ARQ NEURO-PSIQUIAT, V54, P94, DOI 10.1590/S0004-282X1996000100015
   MACHADO ADB, 1988, REV SAUDE PUBL, V22, P240
   MEDINA MT, 1990, ARCH INTERN MED, V150, P325, DOI 10.1001/archinte.150.2.325
   SCHANTZ PM, 1994, CLIN INFECT DIS, V18, P879, DOI 10.1093/clinids/18.6.879
   Sousa AD, 1998, AM J TROP MED HYG, V58, P759, DOI 10.4269/ajtmh.1998.58.759
   Spina-Franca A, 1976, Arq Neuropsiquiatr, V34, P40
   Takayanagui O M, 1990, Arq Neuropsiquiatr, V48, P1
   Takayanagui O M, 1983, Arq Neuropsiquiatr, V41, P50
   Trevisol-Bittencourt PC, 1998, ARQ NEURO-PSIQUIAT, V56, P53, DOI 10.1590/S0004-282X1998000100008
   TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50
NR 17
TC 7
Z9 10
U1 0
U2 0
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 2000
VL 58
IS 3A
BP 621
EP 624
DI 10.1590/S0004-282X2000000400004
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 349AR
UT WOS:000089022100004
PM 10973100
OA DOAJ Gold, Green Published
DA 2020-12-15
ER

PT J
AU Darze, C
   Lucena, R
   Gomes, I
   Melo, A
AF Darze, C
   Lucena, R
   Gomes, I
   Melo, A
TI Prognostic factors in cryptococcal meningoencephalitis
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE cryptococcosis; Cryptococcus neoformans; meningitis;
   meningoencephalitis; prognosis
ID ACQUIRED IMMUNODEFICIENCY SYNDROME; NEOFORMANS INFECTION;
   AMPHOTERICIN-B; MENINGITIS; AIDS; DISEASE; SPECTRUM; FEATURES; VIRUS
AB Objective: To identify demographic, clinical and cerebrospinal fluid (CSF) variables associated to intrahospitalar lethality of patients with cryptococcal meningoencephalitis. Study design: Retrospective cohort to study prognosis. Setting: Hospital Couto Maia (HCMaia) reference for patients with infectious diseases in the State of Bahia Northeastern Brazil. Population: Patients admitted at HCMaia, from 1972 to 1996, with the diagnosis of cryptococcal meningoencephalitis. Results: Lethality rate was 42.7%. The most important neurological abnormalities were neck stiffness, decreased consciousness level, behavior changes, cranial nerve palsy and Visual alterations. Disease time over 30 days, involvement of consciousness level and cerebrospinal fluid cells under 40/mm(3) were associated to a higher lethality rate. Conclusion: Disease time over 30 days, involvement of consciousness level, and CSF decreased cellularity were the only predictors of lethality in the studied population.
C1 Univ Fed Bahia, Div Neuroinfectol & Neuroepidemiol, BR-41170290 Salvador, BA, Brazil.
   Univ Fed Bahia, Hosp Univ Professor Edgard Santos, Serv Neurol, BR-41170290 Salvador, BA, Brazil.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR BUTLER WT, 1964, NEW ENGL J MED, V270, P59, DOI 10.1056/NEJM196401092700201
   CALVO B, 1991, REV I MED TROP, V33, P485, DOI 10.1590/S0036-46651991000600009
   CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205
   CLARK RA, 1990, REV INFECT DIS, V12, P768
   DarrasJoly C, 1996, CLIN INFECT DIS, V23, P369, DOI 10.1093/clinids/23.2.369
   DARZE C, UNPUB REV SOC BRASME
   DIAMOND RD, 1974, ANN INTERN MED, V80, P176, DOI 10.7326/0003-4819-80-2-176
   DISMUKES WE, 1987, NEW ENGL J MED, V317, P334, DOI 10.1056/NEJM198708063170602
   DISMUKES WE, 1988, J INFECT DIS, V157, P624, DOI 10.1093/infdis/157.4.624
   KOVACS JA, 1985, ANN INTERN MED, V103, P533, DOI 10.7326/0003-4819-103-4-533
   LEWIS JL, 1972, AM J MED, V53, P315, DOI 10.1016/0002-9343(72)90174-X
   MITCHELL DH, 1995, CLIN INFECT DIS, V20, P611, DOI 10.1093/clinids/20.3.611
   MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515
   Nunes C, 1996, ARQ NEURO-PSIQUIAT, V54, P222, DOI 10.1590/S0004-282X1996000200008
   Reis-Filho Joao Baptista Dos, 1994, Revista do Instituto de Medicina Tropical de Sao Paulo, V36, P225
   SAAG MS, 1992, NEW ENGL J MED, V326, P83, DOI 10.1056/NEJM199201093260202
   SPICKARD A, 1963, ANN INTERN MED, V58, P66, DOI 10.7326/0003-4819-58-1-66
   WHITE M, 1992, J INFECT DIS, V165, P960, DOI 10.1093/infdis/165.5.960
   ZUGER A, 1986, ANN INTERN MED, V104, P234, DOI 10.7326/0003-4819-104-2-234
NR 19
TC 5
Z9 6
U1 0
U2 2
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1999
VL 57
IS 3A
BP 649
EP 652
DI 10.1590/S0004-282X1999000400018
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 228WH
UT WOS:000082159200018
PM 10667291
OA Green Published, Other Gold
DA 2020-12-15
ER

PT J
AU Nunes, C
   Cunha, S
   Gomes, I
   Lucena, R
   Moraes, D
   Melo, A
AF Nunes, C
   Cunha, S
   Gomes, I
   Lucena, R
   Moraes, D
   Melo, A
TI Prognostic factors for tuberculous meningoencephalitis lethality
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE tuberculous meningitis; central nervous system tuberculosis;
   neuro-tuberculosis; prognostic
ID MENINGITIS
AB In order to describe the lethality predictors of patients with tuberculous meningoencephalitis, records of 231 patients were analysed. Ages ranged from less than I year to 68 years. Ninety-seven patients (42%) were four years old or less. Apart from 73.2% of patients whose diagnosis was performed by clinical and epidemiologic criteria associated with response to specific therapy, 26.8% had diagnostic confirmation through cerebrospinal fluid (culture, bacilloscopy, PCR) or necropsy. The lethality predictors were: less than 4 years of age, seizures, and severe alterations of consciousness.
C1 Hosp Couto Maia, Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med, Dept Prevent Med, BR-41170290 Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Med, Dept Neuropsiquiatria, Div Neuroinfectol & Neuroepidemiol, BR-41170290 Salvador, BA, Brazil.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR AZAMBUJA HCP, 1993, TUBERCULOSE EPIDEMIO, P433
   *BRAS MIN SAUD, 1995, MAN NORM CONTR TUB
   *BRAS MIN SAUD, 1992, CONTR TUB UM PROP IN
   CARRASCO EC, 1988, ENFERM CIR TOR, V4, P122
   Catanzaro A, 1996, LANCET, V347, P1500, DOI 10.1016/S0140-6736(96)90666-2
   DAVIS LE, 1993, NEUROLOGY, V43, P1775, DOI 10.1212/WNL.43.9.1775
   Gomes I, 1996, ARQ NEURO-PSIQUIAT, V54, P407, DOI 10.1590/S0004-282X1996000300008
   HOLDINESS MR, 1990, DRUGS, V39, P224, DOI 10.2165/00003495-199039020-00006
   KENNEDY DH, 1979, JAMA-J AM MED ASSOC, V241, P264, DOI 10.1001/jama.241.3.264
   MARTINS TS, 1985, J BRAS MED, V4, P34
   Misra UK, 1996, J NEUROL SCI, V137, P57, DOI 10.1016/0022-510X(95)00334-X
   Nunes C, 1996, ARQ NEURO-PSIQUIAT, V54, P222, DOI 10.1590/S0004-282X1996000200008
   Singh N K, 1985, J Indian Med Assoc, V83, P50
   VALENZUELA MT, 1988, ENFERMEDADES RESPIRA, V4, P124
   WUNSCH V, 1990, B WORLD HEALTH ORGAN, V68, P69
   ZUGER A, 1991, INFECT CENTRAL NERVO, P425
NR 16
TC 5
Z9 6
U1 0
U2 3
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 1998
VL 56
IS 4
BP 772
EP 777
DI 10.1590/S0004-282X1998000500012
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 143AJ
UT WOS:000077232700012
PM 10029881
OA Other Gold, Green Published
DA 2020-12-15
ER

PT J
AU Lucena, R
   Gomes, I
   Goes, J
   Melo, A
AF Lucena, R
   Gomes, I
   Goes, J
   Melo, A
TI Survival analysis of acute pyogenic meningitis in children
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE acute pyogenic meningitis; children; survival analysis; lethality
ID BACTERIAL-MENINGITIS; ETIOLOGY
AB In order to determine the survival curves of lethality in acute bacteral meningitis (ABM) in children, we reviewed the charts of all patients admitted to the Hospital Couto Maia from January 1990 to December 1992. The Kaplan-Meir analysis was used to compare the survival rate and hospitalar permanence of patients with identified pathogens with those whose bacteria were not determined. The same analysis was used to compare the curves of the three most frequent agents. Statistical difference between the identified and nonidentified groups was not observed. The analysis of the three curves shows that the first 24 hours were responsible for the most elevated lethality rate. When the curves are compared, it is clear that S. pneumoniae has the most important intrahospitalar lethality and N. meningitidis the most benign evolution. We conclude that efforts have to be made to determine which variables are related to prognosis of ABM at the first day of hospital admission.
C1 Univ Fed Bahia, Serv Neurol, BR-41170290 Salvador, BA, Brazil.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR Akpede G O, 1995, West Afr J Med, V14, P217
   ANDERSEN J, 1995, J INFECTION, V31, P115, DOI 10.1016/S0163-4453(95)92085-4
   ANTTILA M, 1994, ACTA PAEDIATR, V83, P63, DOI 10.1111/j.1651-2227.1994.tb12954.x
   Bhat B V, 1991, J Indian Med Assoc, V89, P224
   BRYAN JP, 1990, REV INFECT DIS, V12, P128
   CADOZ M, 1981, B WORLD HEALTH ORGAN, V59, P575
   Decazes J M, 1995, Rev Prat, V45, P607
   Fletcher RH, 1996, CLIN EPIDEMIOLOGY ES, P111
   FORD H, 1994, J EPIDEMIOL COMMUN H, V48, P276, DOI 10.1136/jech.48.3.276
   Gomes I, 1996, ARQ NEURO-PSIQUIAT, V54, P407, DOI 10.1590/S0004-282X1996000300008
   Lucena R, 1996, ARQ NEURO-PSIQUIAT, V54, P571, DOI 10.1590/S0004-282X1996000400004
   OZUMBA UC, 1995, CTR AFR J MED, V41, P93
   SALAUNSARAUX P, 1995, MED TROP-MARSEILLE, V55, P5
   WRIGHT JP, 1995, TROP DOCT, V25, P5, DOI 10.1177/004947559502500102
NR 14
TC 1
Z9 2
U1 0
U2 1
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD MAR
PY 1998
VL 56
IS 1
BP 88
EP 92
DI 10.1590/S0004-282X1998000100014
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA ZC303
UT WOS:000072563500014
PM 9686126
OA Other Gold, Green Published
DA 2020-12-15
ER

PT J
AU Gomes, I
   Lucena, R
   Melo, A
AF Gomes, I
   Lucena, R
   Melo, A
TI Clinical and laboratorial characteristics of pyogenic meningitis in
   adults
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE bacterial meningitis; adults; septicemia; central nervous system
   infection
ID BACTERIAL-MENINGITIS; CHILDREN; PATHOPHYSIOLOGY
AB We reviewed the charts of 176 adult patients, admitted with a diagnosis of acute bacterial meningitis, in the Hospital Couto Maia, from January 1990 to December 1992. All the patients had community-acquired meningitis. In 120 patients we could identify the causative agent on Gram's staining and culture. The most common pathogens were N. meningitidis (56.7%) S. pneumoniae (37.5%) and E. coli (3.3%). The overall lethality rate was 19.8% and the lethality was greater in the group with streptococcus meningitis (31.8%). The mean age and the leukocyte in the peripheral blood were greater in the group with S. pneumoniae meningitis than in the meningococal group. Cutaneous hemorrhagic lesions was an excellent predictor meningococcal meningitis.
C1 UNIV FED BAHIA,HOSP COUTO MAIA,DIV NEUROEPIDEMIOL & NEUROINFECTOL,DEPT PSIQUIATRIA,BR-40110100 SALVADOR,BA,BRAZIL.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008
   BRYAN JP, 1990, REV INFECT DIS, V12, P128
   CADOZ M, 1981, B WORLD HEALTH ORGAN, V59, P575
   Cherigo-Quiros E A, 1984, Rev Med Panama, V9, P35
   DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104
   Gomes I, 1996, ARQ NEURO-PSIQUIAT, V54, P407, DOI 10.1590/S0004-282X1996000300008
   JULIET C, 1983, REV MED CHILE, V111, P690
   Lucena R, 1996, ARQ NEURO-PSIQUIAT, V54, P571, DOI 10.1590/S0004-282X1996000400004
   PFISTER HW, 1993, ARCH NEUROL-CHICAGO, V50, P575, DOI 10.1001/archneur.1993.00540060015010
   QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208
   SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700
   TUNKEL AR, 1990, ANN INTERN MED, V112, P610, DOI 10.7326/0003-4819-112-8-610
NR 12
TC 2
Z9 2
U1 0
U2 1
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1997
VL 55
IS 3B
BP 584
EP 587
DI 10.1590/S0004-282X1997000400012
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA XZ273
UT WOS:A1997XZ27300012
PM 9629410
OA Green Published, Other Gold
DA 2020-12-15
ER

PT J
AU Lucena, R
   Gomes, I
   Melo, A
AF Lucena, R
   Gomes, I
   Melo, A
TI Laboratorial and clinical variables to the differential diagnosis
   between aseptic and pyogenic meningitis in children
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Portuguese
DT Article
DE meningitis; children; acute meningitis; diagnosis; aseptic meningitis;
   bacterial meningitis
ID BACTERIAL-MENINGITIS; CEREBROSPINAL-FLUID
AB We reviewed the charts of 573 children with a final diagnosis of pyogenic or aseptic meningitis, who were hospitalized in a large reference hospital for the treatment of infectious disease, from January 1940 to December 1992. Seizures, decreased consciousness, nuchal rigidity were more frequent in bacterial than in aseptic meningitis. A cerebrospinal fluid (CSF) glucose level lower than 45 mg/dL, a protein level equal or greater than 140 mg/dL and cell count greater than 600/mm(3) were predictors of pyogenic meningitis. Receiver operating characteristic curve analysis was used to assess the best point in CSF measures of leukocytes, glucose and protein that could predict bacterial meningitis. These results suggest that clinicians should differentiate bacterial from aseptic meningitis in children with greater accuracy utilizing only clinical and simple CSF data.
C1 UNIV FED BAHIA,HOSP COUTO MAIA,UNIDADE NEUROEPIDEMIOL & NEUROINFECTOL,BR-41170290 SALVADOR,BA,BRAZIL.
   UNIV FED BAHIA,DEPT NEUROPSIQUIATRIA,BR-41170290 SALVADOR,BA,BRAZIL.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008
   BRYAN JP, 1990, REV INFECT DIS, V12, P128
   CADOZ M, 1981, B WORLD HEALTH ORGAN, V59, P575
   DALTON M, 1991, DEV MED CHILD NEUROL, V33, P446
   DULKERIAN SJ, 1995, J PEDIATR-US, V126, P872, DOI 10.1016/S0022-3476(95)70199-0
   Gomes I, 1996, ARQ NEURO-PSIQUIAT, V54, P407, DOI 10.1590/S0004-282X1996000300008
   HASHIM IA, 1995, ANN CLIN BIOCHEM, V32, P289, DOI 10.1177/000456329503200305
   LOPEZCORTES LF, 1995, J INFECT DIS, V172, P581, DOI 10.1093/infdis/172.2.581
   Lucena R, 1996, ARQ NEURO-PSIQUIAT, V54, P571, DOI 10.1590/S0004-282X1996000400004
   MOOSA AA, 1995, LANCET, V345, P1290, DOI 10.1016/S0140-6736(95)90931-1
   RODEWALD LE, 1991, J PEDIATR-US, V119, P363, DOI 10.1016/S0022-3476(05)82046-3
   SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700
NR 12
TC 0
Z9 1
U1 0
U2 2
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1997
VL 55
IS 3B
BP 588
EP 593
DI 10.1590/S0004-282X1997000400013
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA XZ273
UT WOS:A1997XZ27300013
PM 9629411
OA Other Gold, Green Published
DA 2020-12-15
ER

PT J
AU Lucena, R
   Gomes, I
   Ferreira, A
   Goes, J
   Araujo, I
   Veiga, M
   Melo, A
AF Lucena, R
   Gomes, I
   Ferreira, A
   Goes, J
   Araujo, I
   Veiga, M
   Melo, A
TI Clinical and laboratorial characteristics of bacterial meningitis in
   children
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA Spanish
DT Article
DE bacterial meningitis; children; clinical and laboratory findings;
   prognosis
AB Data from the records of 528 children under 15 years old with diagnosis of acute bacterial meningitis, admitted at the Hospital Couto Maia between 1990 and 1992 were analyzed. Bacterial meningitis was more frequent in children under the age of 1 year (37.8%). The most common etiologic agent was H. influenzae (42.2%). The global letality was 20.9%. Individual predictors of poor outcome were: absence of the ''classic triad'', CSF cell count under 1000/mm(3), age under 2 years, presence of seizures, depressed sensorium, and S. pneumoniae as causal agent.
C1 UNIV FED BAHIA,SERV NEUROL,BR-41170290 SALVADOR,BA,BRAZIL.
RI Lucena, Rita/L-9842-2013; FILHO, IRAMI ARAUJO/C-2258-2014
OI Lucena, Rita/0000-0002-6190-9168; FILHO, IRAMI
   ARAUJO/0000-0003-2471-7447; Melo, Ailton/0000-0001-7457-0573
CR BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008
   BLAZER S, 1993, AM J CLIN PATHOL, V80, P386
   BRYAN JP, 1990, REV INFECT DIS, V12, P128
   CADOZ M, 1981, B WORLD HEALTH ORGAN, V59, P575
   DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104
   FAHRAT CK, 1987, DOENCAS INFECCIOSAS, P365
   FEIGIN RD, 1987, TXB PEDIAT INFECT DI, P831
   Gomes I, 1996, ARQ NEURO-PSIQUIAT, V54, P407, DOI 10.1590/S0004-282X1996000300008
   GREENWOOD BM, 1984, REV INFECT DIS, V6, P374
   JULIET C, 1983, REV MED CHILE, V111, P690
   KLEIN JO, 1986, PEDIATRICS S, V78, P952
   MARTON KI, 1986, ANN INTERN MED, V104, P840, DOI 10.7326/0003-4819-104-6-840
   SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700
   WENGER JD, 1990, J INFECT DIS, V162, P1316, DOI 10.1093/infdis/162.6.1316
   Wispelwey B, 1990, Infect Dis Clin North Am, V4, P645
NR 15
TC 10
Z9 10
U1 0
U2 1
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD DEC
PY 1996
VL 54
IS 4
BP 571
EP 576
DI 10.1590/S0004-282X1996000400004
PG 6
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA VV486
UT WOS:A1996VV48600004
PM 9201336
OA Other Gold
DA 2020-12-15
ER

PT J
AU Gomes, I
   Melo, A
   Lucena, R
   CunhaNascimento, MH
   Ferreira, A
   Goes, J
   Barreto, I
   Jones, N
   Gaspari, V
   Embirucu, EK
   Veiga, M
AF Gomes, I
   Melo, A
   Lucena, R
   CunhaNascimento, MH
   Ferreira, A
   Goes, J
   Barreto, I
   Jones, N
   Gaspari, V
   Embirucu, EK
   Veiga, M
TI Prognosis of bacterial meningitis in children
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Article
DE pyogenic meningitis; bacterial meningitis; septicemia; meningitis in
   children
ID CONTROLLED TRIALS; DEXAMETHASONE; ADULTS; PATHOPHYSIOLOGY; COMPLICATIONS
AB We studied the incidence and prognosis of acute neurologic complications in 281 children under 13 years of age with a diagnosis of acute bacterial meningitis. All the patients were examined daily by the same group of neurologists, using a standardized neurological examination. Patients with signs of encephalic lesions, unsatisfactory response to antibiotics or decreased level of consciousness were submitted to brain computer tomography. The overall lethality rate was 20.3% and cases whose causative agent was identified presented a higher lethality rate (23.7%) than those in which the agent was not found. The most important neurological abnormalities were meningeal signs (88.3%) followed by decreased consciousness (47.7%), irritability (35.2%), seizures (22.4%), fontanel bulging (20.6%) and cranial nerve palsy (14.2%). Seizures, cranial nerve palsy and the absence of meningeal signs were related to higher rates of lethality. Diminished consciousness, seizures, subdural effusion, abscess and hydrocephalus were the most important complications, respectively. We can conclude that acute bacterial meningitis continues to be an important health problem in developing countries and that public health measures will be necessary to minimize the impact of sequelae and reduce the mortality rate in children with that pathology.
C1 UNIV FED BAHIA, HOSP UNIV PROF EDGARD SANTOS, SERV NEUROL, SALVADOR, BA, BRAZIL.
RI Lucena, Rita/L-9842-2013
OI Lucena, Rita/0000-0002-6190-9168; Melo, Ailton/0000-0001-7457-0573
CR BRYAN JP, 1990, REV INFECT DIS, V12, P128
   CADOZ M, 1981, B WORLD HEALTH ORGAN, V59, P575
   FERREIRA A, 1995, J NEUROL S, V242, pS115
   GEIMAN BJ, 1992, WESTERN J MED, V157, P27
   GIRGIS NI, 1989, PEDIATR INFECT DIS J, V8, P848, DOI 10.1097/00006454-198912000-00004
   HERSON VC, 1977, PEDIATRICS, V59, P35
   LEBEL MH, 1988, NEW ENGL J MED, V319, P964, DOI 10.1056/NEJM198810133191502
   ODIO CM, 1991, NEW ENGL J MED, V324, P1525, DOI 10.1056/NEJM199105303242201
   PFISTER HW, 1993, ARCH NEUROL-CHICAGO, V50, P575, DOI 10.1001/archneur.1993.00540060015010
   PFISTER HW, 1992, NEUROLOGY, V42, P1497, DOI 10.1212/WNL.42.8.1497
   QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208
   SCHLESINGER LS, 1987, MEDICINE, V66, P148, DOI 10.1097/00005792-198703000-00006
   SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700
   TUNKEL AR, 1990, ANN INTERN MED, V112, P610, DOI 10.7326/0003-4819-112-8-610
NR 14
TC 15
Z9 15
U1 0
U2 2
PU ASSOC ARQUIVOS DE NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA C/O DR OSWALDO LANGE, CAIXA POSTAL 8877, 01065-970 SAO PAULO SP, BRAZIL
SN 0004-282X
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD SEP
PY 1996
VL 54
IS 3
BP 407
EP 411
DI 10.1590/S0004-282X1996000300008
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA VE335
UT WOS:A1996VE33500008
PM 9109984
OA Green Published, Other Gold
DA 2020-12-15
ER

EF